🏷

Classifications

ISDS Skeletal Nosology

👪

Inheritance

1

Autosomal Dominant

Autosomal dominant inheritance with marked intra- and interfamilial variable expressivity. TBX3 haploinsufficiency is the predominant pathogenic mechanism for most loss-of-function variants (frameshift, nonsense, splice-site), but mouse genetic studies indicate that some truncating alleles produce mislocalized proteins with phenotypes distinct from a true null, so not all UMS variants behave as simple nulls.

Show evidence (3 references)

PMID:9207801 SUPPORT Human Clinical

"Each mutation (a single nucleotide deletion and a splice-site mutation) is predicted to cause haploinsufficiency of TBX3, implying that critical levels of this transcription factor are required for morphogenesis of several organs"

Demonstrates that TBX3 haploinsufficiency from heterozygous loss-of-function mutations is the pathogenic mechanism in autosomal dominant UMS.

PMID:8923944 SUPPORT Human Clinical

"The clinical expression of UMS is highly variable."

Pallister kindred analysis directly establishes the marked variable expressivity that characterizes autosomal dominant TBX3-related disease.

PMID:23844108 SUPPORT Model Organism

"not all mutations observed in humans generate functionally null alleles. The possibility that mechanisms in addition to TBX3 haploinsufficiency may cause UMS or other malformations merits investigation"

Mouse Tbx3 mutant alleles show that some truncating variants produce mislocalized cytoplasmic protein with phenotypes distinct from true nulls, qualifying the simple haploinsufficiency model.

⚙

Pathophysiology

5

TBX3 Haploinsufficiency

Heterozygous loss-of-function variants in TBX3 (a T-box DNA-binding transcriptional repressor on chromosome 12q24.21) reduce functional protein dosage below the level required for several developmental programs. Variants include frameshift, nonsense, splice-site, and missense changes both within and outside the T-box DNA-binding domain; missense variants in the T-box domain are functionally most disruptive, consistent with the genotype-phenotype trend that T-box-disrupting variants cause more severe limb and dental phenotypes. Mouse data indicate that some engineered truncating alleles produce cytoplasmically mislocalized protein, so a subset of human variants may act through mechanisms beyond simple loss of function. Reduced TBX3 dosage is the upstream lesion that converges on tissue-specific transcriptional programs in the limb bud, mammary placode, hypothalamic-pituitary axis, and cardiac conduction system.

TBX3 hgnc:11602

Negative Regulation of Transcription by RNA Polymerase II GO:0000122 ↓ DECREASED

Animal models

Humanized TBX3 model expressing p.P134S and comparison variants Drosophila melanogaster Drosophila melanogaster Tests how disease-associated variants alter TBX3 activity and localization in a developmental context.

Downstream

Posterior Limb Patterning Disruption Reduced TBX3 dosage in posterior limb bud mesenchyme fails to repress anterior gene boundaries, disrupting the anterior-posterior axis necessary for ulnar/posterior digit specification.

Apocrine Gland Development Failure Reduced TBX3 in mammary placode ectoderm fails to maintain placode identity and ductal branching, disrupting breast/nipple and apocrine gland morphogenesis.

Hypothalamic-Pituitary Axis Disruption Reduced TBX3 dosage during pituitary morphogenesis produces anterior pituitary hypoplasia (and ectopic posterior pituitary in some cases), manifesting clinically as hypogonadotropic hypogonadism and growth hormone deficiency.

Cardiac Conduction System Disruption Reduced TBX3 dosage in cardiac progenitors fails to specify the AV conduction system and to repress accessory AV pathways, producing conduction block and/or pre-excitation phenotypes.

Show evidence (5 references)

PMID:9207801 SUPPORT Human Clinical

"Each mutation (a single nucleotide deletion and a splice-site mutation) is predicted to cause haploinsufficiency of TBX3, implying that critical levels of this transcription factor are required for morphogenesis of several organs"

Original disease-gene paper demonstrating that heterozygous TBX3 loss-of-function variants cause UMS via haploinsufficiency.

PMID:10330342 SUPPORT Human Clinical

"Novel mutations have been found in all of eight newly reported families with UMS, including five mutations downstream of the region encoding the T-box"

Establishes the breadth of the TBX3 mutation spectrum, including pathogenic variants outside the T-box DNA-binding domain.

PMID:16530712 SUPPORT Human Clinical

"an association between mutations that disrupt the DNA-binding domain and a higher frequency of severe upper limb malformations and teeth defects"

Demonstrates the genotype-phenotype gradient by which T-box-disrupting variants cause more severe limb and tooth phenotypes than non-T-box variants.

+ 2 more references

Posterior Limb Patterning Disruption

During early limb-bud development, TBX3 establishes the posterior expression boundary of anterior identity genes by transcriptional repression that excludes Gli3, Alx4, Hand1, and Irx3/5 from the posterior limb bud mesenchyme. This exclusion delineates a posterior territory competent to establish the Sonic-hedgehog-expressing zone of polarizing activity (ZPA). HAND2 cooperates with TBX3 to upregulate shared posterior identity targets and is required for SHH activation. TBX3 is itself a direct transcriptional target of retinoic acid signaling via an RA-receptor complex bound to the TBX3 promoter, placing RA upstream of TBX3 in limb patterning. Haploinsufficiency disrupts posterior limb morphogenesis, causing ulnar ray defects ranging from fifth finger hypoplasia to complete ulnar absence; posterior digital duplications also occur. Limb defects of UMS specifically affect posterior elements, in mirror-image contrast to the anterior radial defects of TBX5-related Holt-Oram syndrome, reflecting the complementary roles acquired by these paralogues.

Limb Bud Mesenchymal Cell CL:0008019

Embryonic Limb Morphogenesis GO:0030326 Anterior/Posterior Pattern Specification GO:0009952 Smoothened (SHH) Signaling Pathway GO:0007224 ↓ DECREASED Retinoic Acid Receptor Signaling Pathway GO:0048384

Animal models

Heterozygous Tbx3 loss-of-function and mammary-development alleles Mus musculus Mus musculus Models TBX3-dependent positioning of the posterior boundary and SHH organizer territory.

Downstream

Ulnar Ray Deficiency Loss of TBX3-mediated posterior boundary specification disrupts establishment of the SHH organizer, producing the cardinal ulnar/posterior limb deficiency of UMS.

Show evidence (3 references)

PMID:38828908 SUPPORT Model Organism

"the posterior expression boundaries of anterior genes are positioned by TBX3-mediated repression, which excludes anterior genes such as Gli3, Alx4, Hand1 and Irx3/5 from the posterior limb bud mesenchyme. This exclusion delineates the posterior mesenchymal territory competent to establish..."

Directly establishes the posterior boundary and organizer mechanism in mouse limb buds.

PMID:9207801 SUPPORT Human Clinical

"Limb abnormalities of ulnar-mammary syndrome involve posterior elements"

Human disease evidence anchors the posterior patterning mechanism to the characteristic limb distribution.

PMID:22535523 SUPPORT Model Organism

"retinoic acid (RA) activates endogenous TBX3 expression, which is mediated by an RA-receptor complex directly binding and activating the TBX3 promoter"

Supports the upstream retinoic-acid component described for this node.

Apocrine Gland Development Failure

TBX3 is required for induction and maintenance of mammary placodes and for ductal branching morphogenesis of the breast and axillary apocrine glands. In mouse embryos, Wnt signaling and FGF8/FGFR1 signaling converge on the surface ectoderm to induce and maintain Tbx3 expression in the prospective mammary bud, where Tbx3 is the earliest known placodal marker (preceding Lef1). Haploinsufficiency reduces placode maintenance and ductal branching in mice, with a genetic interaction with Tbx2 that does not require the p19Arf/p53 pathway. In the adult mammary gland TBX3 is restricted to luminal hormone-sensing (estrogen-receptor-positive) cells and is required for generation of this lineage. Human UMS series group breast/nipple hypoplasia, diminished axillary perspiration, absent axillary hair, and hypohidrosis as the characteristic apocrine phenotype; axillary hair loss is retained as an association rather than assigned a specific causal route.

Mammary Stem/Progenitor Cell CL:0002451 Luminal Hormone-Sensing Mammary Cell CL:4033058 Apocrine Cell CL:0000033

Mammary Gland Development GO:0030879 ↓ DECREASED Mammary Placode Formation GO:0060596 ↓ DECREASED Mammary Gland Morphogenesis GO:0060443 ↓ DECREASED Wnt Signaling Pathway GO:0016055

Animal models

Heterozygous Tbx3 loss-of-function and mammary-development alleles Mus musculus Mus musculus Models the dosage-sensitive mammary placode and ductal branching defect.

Downstream

Breast Hypoplasia Reduced TBX3 dosage during mammary placode formation and branching morphogenesis produces hypoplasia of the breast and nipple.

Hypoplastic Nipples The dosage-sensitive mammary placode defect provides a supported developmental route to hypoplastic nipples and areolae.

Hypohidrosis Human clinical series classify diminished or absent axillary perspiration within the apocrine-gland abnormality spectrum, although the intervening developmental steps are not resolved.

Show evidence (5 references)

PMID:9207801 SUPPORT Human Clinical

"Ulnar-mammary syndrome is a rare pleiotropic disorder affecting limb, apocrine gland, tooth and genital development"

Establishes apocrine gland involvement (including breast) as a defining feature of UMS.

PMID:15255957 SUPPORT Model Organism

"Tbx3 expression is induced and maintained in early gland initiation by both Wnt and Fgf signalling through FGFR1"

Mouse embryo data place Wnt and FGFR1 signaling upstream of Tbx3 in mammary placode initiation, identifying the molecular cascade that fails in UMS apocrine hypoplasia.

PMID:16222716 SUPPORT Model Organism

"we show a haploinsufficiency effect of Tbx3 on maintenance of the mammary placodes and on the extent of branching of the ductal tree in mice"

Direct mouse-genetic demonstration that Tbx3 haploinsufficiency impairs mammary placode maintenance and ductal branching - the developmental basis of UMS breast hypoplasia.

+ 2 more references

Hypothalamic-Pituitary Axis Disruption

TBX3 is expressed in the developing pituitary gland, and recurrent structural pituitary findings in UMS - anterior pituitary hypoplasia, thin pituitary stalk, and ectopic posterior pituitary - implicate TBX3 dosage in adenohypophysis development. The clinical consequence is congenital normosmic hypogonadotropic hypogonadism (often persistent into adulthood), partial growth hormone deficiency, and short stature; a combined-cohort analysis found delayed puberty in 79% of UMS males and other signs of hypogonadism in 37%. The endocrine phenotype can be the presenting (or only) feature, even without overt limb or mammary signs, so TBX3 belongs in the diagnostic differential for congenital nIHH with midline defects.

Gonadotroph CL:0000437 Somatotroph CL:0002312

Adenohypophysis Development GO:0021984 ↓ DECREASED Pituitary Gland Development GO:0021983 ↓ DECREASED

Downstream

Hypogonadotropic Hypogonadism Gonadotroph hypoplasia produces inadequate LH/FSH drive of the gonadal axis, manifesting as nIHH and delayed/absent puberty.

Anterior Pituitary Hypoplasia Reduced TBX3 dosage in pituitary anlage produces anatomic anterior pituitary hypoplasia on MRI.

Growth Hormone Deficiency Somatotroph dysfunction in the hypoplastic anterior pituitary reduces GH secretion, contributing to short stature.

Short Stature Combined GH deficiency and pubertal delay produce short stature that can respond to recombinant human GH and gonadotropin therapy.

Delayed Puberty Reduced gonadotropin output delays or prevents pubertal onset, especially in males.

Show evidence (6 references)

PMID:30550377 SUPPORT Human Clinical

"the existence of congenital normosmic IHH (nIHH) associated with pituitary hypoplasia in the two probands who were heterozygous for novel TBX3 pathogenic variants"

Direct clinical demonstration that TBX3 pathogenic variants cause congenital normosmic hypogonadotropic hypogonadism with pituitary hypoplasia.

PMID:30550377 SUPPORT Human Clinical

"delayed puberty and other signs of hypogonadism in 79 and 37% of UMS males, respectively"

Provides population-level frequency estimates anchoring the hypogonadotropic-hypogonadism phenotype in UMS males.

PMID:30550377 SUPPORT Human Clinical

"TBX3 should be included among candidate genes for congenital nIHH"

Establishes TBX3 as a candidate gene for isolated congenital normosmic IHH, beyond classic UMS diagnostic settings.

+ 3 more references

Cardiac Conduction System Disruption

TBX3 plays a dichotomous role in patterning the atrioventricular (AV) conduction system: it specifies the development of the normal AV conduction tissue (AV node, His bundle, bundle branches) and represses the formation of accessory AV pathways elsewhere in working myocardium. Haploinsufficiency therefore produces a bidirectional electrical phenotype - conduction block from inadequate AV-node/Purkinje specification, and ventricular pre-excitation (Wolff-Parkinson-White pattern) from failure to suppress accessory pathways. TBX3 may also maintain postnatal conduction-system health, supporting adult-onset sinus-node dysfunction and AV block in carriers.

Cardiac Conduction System Development GO:0003161 ↓ DECREASED

Downstream

Cardiac Conduction Abnormality TBX3 dosage is required both to specify normal conduction tissue and to suppress accessory pathways; loss produces WPW-pattern pre-excitation and/or conduction block.

Show evidence (4 references)

PMID:30820409 SUPPORT Human Clinical

"TBX3 both specifies the development of the normal atrioventricular conduction system and suppresses abnormal, accessory atrioventricular pathways elsewhere"

Defines the dichotomous TBX3 role - specifying normal AV conduction tissue and repressing accessory pathways - that explains both conduction block and pre-excitation phenotypes in UMS.

PMID:30820409 SUPPORT Human Clinical

"Patients with TBX3 mutations should be evaluated for conduction block and ventricular preexcitation"

Direct clinical recommendation that TBX3 carriers be screened for both conduction block and pre-excitation, supporting cardiac surveillance.

PMID:30820409 SUPPORT Human Clinical

"Patients with TBX3 mutations should be followed for the possibility of developing adult-onset conduction disease"

Establishes a postnatal-maintenance role for TBX3 in conduction-system health, motivating long-term electrophysiologic follow-up.

+ 1 more reference

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

20

Breast 1

Breast Hypoplasia HP:0003187

Show evidence (3 references)

PMID:9207801 SUPPORT Human Clinical

"Ulnar-mammary syndrome is a rare pleiotropic disorder affecting limb, apocrine gland, tooth and genital development"

Apocrine/mammary gland involvement is a defining feature of UMS.

PMID:8923944 SUPPORT Human Clinical

"Apocrine gland abnormalities range from diminished axillary perspiration with normal breast development and lactation, to complete absence of the breasts and no axillary perspiration"

Pallister kindred analysis documents the spectrum of breast hypoplasia/aplasia in UMS.

PMID:16222716 SUPPORT Model Organism

"we show a haploinsufficiency effect of Tbx3 on maintenance of the mammary placodes and on the extent of branching of the ductal tree in mice"

Mouse-genetic basis for the human breast hypoplasia phenotype - Tbx3 dosage controls mammary placode maintenance and ductal branching.

Cardiovascular 2

Ventricular Septal Defect HP:0001629

Show evidence (1 reference)

PMID:19938096 SUPPORT Human Clinical

"ventricular septal defect (VSD), and cardiac conduction defects consistent with Wolff-Parkinson-White (WPW) syndrome"

Documents VSD with WPW-pattern conduction defects in TBX3-mutation-confirmed UMS.

Cardiac Conduction Abnormality Wolff-Parkinson-White syndrome HP:0001716

Show evidence (1 reference)

PMID:19938096 SUPPORT Human Clinical

"cardiac conduction defects consistent with Wolff-Parkinson-White (WPW) syndrome"

Documents WPW-pattern conduction defect in TBX3-mutation-confirmed UMS, supporting cardiac surveillance recommendations.

Endocrine 4

Delayed Puberty HP:0000823

Course: STABLE

Show evidence (2 references)

PMID:30550377 SUPPORT Human Clinical

"delayed puberty and other signs of hypogonadism in 79 and 37% of UMS males, respectively"

Provides cohort-level frequency of delayed puberty in UMS males, anchoring this as a high-frequency phenotype.

PMID:8923944 SUPPORT Human Clinical

"Affected males consistently undergo delayed puberty"

Pallister kindred clinical analysis supports consistent delayed puberty in affected males.

Hypogonadotropic Hypogonadism HP:0000044

Show evidence (2 references)

PMID:30550377 SUPPORT Human Clinical

"the existence of congenital normosmic IHH (nIHH) associated with pituitary hypoplasia in the two probands who were heterozygous for novel TBX3 pathogenic variants"

Direct clinical demonstration of congenital nIHH co-segregating with TBX3 pathogenic variants and pituitary hypoplasia.

PMID:39788453 SUPPORT Human Clinical

"Endocrine abnormalities include hypogonadotropic hypogonadism (HH), partial growth hormone deficiency"

Recent family report frames hypogonadotropic hypogonadism and GH deficiency as canonical TBX3-related endocrine findings.

Anterior Pituitary Hypoplasia HP:0010627

Show evidence (2 references)

PMID:19938096 SUPPORT Human Clinical

"a hypoplastic anterior pituitary and an ectopic posterior pituitary gland"

Documents anterior pituitary hypoplasia and ectopic posterior pituitary as TBX3-related structural pituitary anomalies.

PMID:40485890 SUPPORT Human Clinical

"pituitary gland hypoplasia with a thin pituitary stalk and loss of a strong signal in the posterior pituitary"

Recent case provides MRI-confirmed pituitary hypoplasia with thin stalk and posterior pituitary signal loss.

Growth Hormone Deficiency Secondary growth hormone deficiency HP:0008240

Show evidence (2 references)

PMID:19938096 SUPPORT Human Clinical

"short stature with associated growth hormone deficiency"

Documents growth hormone deficiency as part of the UMS endocrine phenotype.

PMID:36937985 SUPPORT Human Clinical

"Laboratory examination revealed hyperthyroidism, growth hormone deficiency, and hypogonadotropic hypogonadism"

Recent case confirms growth hormone deficiency in a TBX3-mutation-confirmed proband.

Genitourinary 3

Micropenis HP:0000054

Show evidence (2 references)

PMID:36937985 SUPPORT Human Clinical

"retracted nipple, micropenis, and cryptorchidism"

Recent case documents micropenis with cryptorchidism in a TBX3-mutation-confirmed proband.

PMID:39788453 SUPPORT Human Clinical

"twin siblings with micropenis, neonatal hypogonadism, and congenital giant bladder diverticula"

Recent family report documents micropenis with neonatal hypogonadism in TBX3-mutation-positive twins.

Cryptorchidism HP:0000028

Show evidence (1 reference)

PMID:19938096 SUPPORT Human Clinical

"short stature with associated growth hormone deficiency, and cryptorchidism"

Documents cryptorchidism in a TBX3-mutation-confirmed UMS patient.

Bladder Diverticulum HP:0000015

Show evidence (1 reference)

PMID:39788453 SUPPORT Human Clinical

"twin siblings with micropenis, neonatal hypogonadism, and congenital giant bladder diverticula"

Documents congenital bladder diverticula in TBX3-mutation-positive twins, extending the genitourinary phenotype.

Head and Neck 1

Hypodontia HP:0000668

Show evidence (2 references)

PMID:8923944 SUPPORT Human Clinical

"Dental abnormalities include misplaced or absent teeth"

Pallister kindred analysis documents dental abnormalities including hypodontia.

PMID:16530712 SUPPORT Human Clinical

"an association between mutations that disrupt the DNA-binding domain and a higher frequency of severe upper limb malformations and teeth defects"

Confirms genotype-phenotype gradient that places dental defects with T-box-disrupting variants.

Integument 2

Absent Axillary Hair HP:0002221

Show evidence (2 references)

PMID:8923944 SUPPORT Human Clinical

"both sexes have diminished to absent axillary hair"

Pallister kindred clinical analysis documents diminished or absent axillary hair as a consistent UMS feature in both sexes.

PMID:16530712 SUPPORT Human Clinical

"typical UMS traits (hypoplasia of the breast and axillary hair, upper limbs and genital defects)"

Absent axillary hair is listed among typical UMS features.

Hypohidrosis HP:0000966

Show evidence (2 references)

PMID:8923944 SUPPORT Human Clinical

"Apocrine gland abnormalities range from diminished axillary perspiration with normal breast development and lactation, to complete absence of the breasts and no axillary perspiration"

Pallister kindred clinical description documents diminished/absent axillary perspiration as part of the apocrine UMS phenotype.

PMID:36937985 SUPPORT Human Clinical

"short stature, ulnar hypoplasia of the forearm, hypohidrosis"

Recent case shows hypohidrosis in a TBX3-mutation-confirmed UMS proband.

Limbs 2

Ulnar Ray Deficiency Hypoplasia of the ulna HP:0003022

Show evidence (3 references)

PMID:9207801 SUPPORT Human Clinical

"Limb abnormalities of ulnar-mammary syndrome involve posterior elements"

Confirms that UMS limb defects specifically affect posterior (ulnar) structures.

PMID:8923944 SUPPORT Human Clinical

"the range of abnormalities extends from hypoplasia of the terminal phalanx of the 5th digit to complete absence of the ulna and 3rd, 4th, and 5th digits"

Pallister kindred analysis documents the full clinical spectrum of posterior limb deficiency in UMS.

PMID:16530712 SUPPORT Human Clinical

"an association between mutations that disrupt the DNA-binding domain and a higher frequency of severe upper limb malformations"

T-box-domain genotype-phenotype gradient applies most strongly to limb severity.

Postaxial Hand Polydactyly HP:0001162

Show evidence (2 references)

PMID:8923944 SUPPORT Human Clinical

"affected individuals may have posterior digital duplications with or without contralateral limb deficiencies"

Pallister kindred documents posterior digital duplications as part of the UMS limb spectrum.

PMID:36140816 SUPPORT Human Clinical

"a one-year-old female with unilateral, postaxial polydactyly, and bilateral fifth fingernail duplication"

Modern case report documents postaxial polydactyly with TBX3 splice-site variant.

Growth 1

Short Stature HP:0004322

Show evidence (2 references)

PMID:19938096 SUPPORT Human Clinical

"bilateral ulnar defects, inverted nipples, short stature with associated growth hormone deficiency"

Documents short stature as a feature of TBX3-mutation-confirmed UMS.

PMID:36748390 SUPPORT Human Clinical

"The proband then was treated with recombinant human growth hormone (rhGH) and human chorionic gonadotropin (hCG). After a year and a half, his height and secondary sexual characteristics were significantly improved."

Modern Chinese family report demonstrates that short stature in UMS responds to rhGH/hCG, anchoring the endocrine basis of the growth phenotype.

Other 4

Hypoplastic Nipples HP:0002557

Show evidence (2 references)

PMID:39320041 SUPPORT Human Clinical

"Core features often present pre-pubertally include defects of the ulna and/or of ulnar ray, hypoplastic nipples and/or areolas"

2024 review/cohort analysis explicitly anchors hypoplastic nipples/areolas as a core prepubertal UMS feature.

PMID:36937985 SUPPORT Human Clinical

"short stature, ulnar hypoplasia of the forearm, hypohidrosis, retracted nipple"

Recent case shows retracted nipple as an apocrine clinical readout in a TBX3-mutation-confirmed UMS proband.

Bifid Nasal Tip HP:0000456

Show evidence (1 reference)

PMID:39788453 SUPPORT Human Clinical

"The physical examination revealed a bifid nasal tip and a bi-lobulated tongue tip typical for UMS"

Recent family report establishes bifid nasal tip as a recognizable UMS feature in atypical presentations.

Bifid Tongue HP:0010297

Show evidence (1 reference)

PMID:39788453 SUPPORT Human Clinical

"a bifid nasal tip and a bi-lobulated tongue tip typical for UMS with no apparent limb or mammary defects"

Documents bilobed tongue tip as a typical UMS midline feature.

Imperforate Hymen HP:0030011

Show evidence (1 reference)

PMID:8923944 SUPPORT Human Clinical

"Imperforate hymen were seen in some affected women"

Pallister kindred clinical analysis documents imperforate hymen in some affected females.

🧬

Genetic Associations

1

TBX3 (Causative)

Gene: TBX3 hgnc:11602

Show evidence (7 references)

PMID:9207801 SUPPORT Human Clinical

"mutations in human TBX3, a member of the T-box gene family, cause ulnar-mammary syndrome"

Original disease-gene paper establishes TBX3 as the causative gene for UMS.

PMID:10330342 SUPPORT Human Clinical

"Novel mutations have been found in all of eight newly reported families with UMS, including five mutations downstream of the region encoding the T-box"

Demonstrates the breadth of the TBX3 mutation spectrum, including pathogenic variants outside the T-box DNA-binding domain.

PMID:10330342 SUPPORT Human Clinical

"We found no obvious phenotypic differences between those who have missense mutations and those who have deletions or frameshifts"

Indicates that mutation type alone does not strongly predict phenotypic severity.

+ 4 more references

💊

Medical Actions

3

Recombinant Human Growth Hormone

Action: Pharmacotherapy NCIT:C15986

Agent: somatropin NCIT:C837

Recombinant human growth hormone (rhGH) replacement for growth hormone deficiency from anterior pituitary hypoplasia. Reported to improve height in UMS probands with confirmed GH deficiency.

Mechanism Target:

Hypothalamic-Pituitary Axis Disruption

Show evidence (1 reference)

PMID:36748390 SUPPORT Human Clinical

"The proband then was treated with recombinant human growth hormone (rhGH) and human chorionic gonadotropin (hCG). After a year and a half, his height and secondary sexual characteristics were significantly improved."

Clinical response supports replacement downstream of the pituitary-axis defect without claiming correction of the developmental lesion.

Target Phenotypes: Short stature HP:0004322 Growth hormone deficiency HP:0008240

Show evidence (1 reference)

PMID:36748390 SUPPORT Human Clinical

"his height and secondary sexual characteristics were significantly"

Treatment with rhGH and hCG significantly improved height and secondary sexual characteristics in a UMS proband.

Testosterone and Gonadotropin Therapy for Pubertal Induction

Action: Pharmacotherapy NCIT:C15986

Testosterone replacement or fertility-preserving FSH plus human chorionic gonadotropin (hCG) regimens can induce puberty in UMS males with persistent hypogonadotropic hypogonadism; hCG can also improve micropenis.

Mechanism Target:

Hypothalamic-Pituitary Axis Disruption

Show evidence (1 reference)

PMID:30550377 SUPPORT Human Clinical

"Human chorionic gonadotrophin was given starting from a dose of 1000 up to 2000 UI twice a week with increments of 500 UI every 6 months and up-titrating the dose according to TTe levels (4, 17, 18)."

The replacement regimen acts downstream of the pituitary lesion and therefore modulates its endocrine consequences rather than the structural defect.

Target Phenotypes: Hypogonadotropic hypogonadism HP:0000044 Delayed puberty HP:0000823 Micropenis HP:0000054

Show evidence (3 references)

PMID:40485890 SUPPORT Human Clinical

"After half a year of treatment with human chorionic gonadotropin (HCG), the micropenis was significantly improved"

hCG therapy improved micropenis in a UMS proband with hypogonadotropic hypogonadism.

PMID:30550377 SUPPORT Human Clinical

"He received testosterone enanthate treatment for 9 months, but at 16 years and 11 months, the testis volume was −4.9 SDS (according to Joustra et al. (15)), and puberty was induced with FSH priming (75 IU for three times a week for 4 months) (16), followed by an induction scheme with FSH (150 IU..."

Documents testosterone use followed by FSH-based pubertal induction in a molecularly confirmed UMS patient.

PMID:30550377 SUPPORT Human Clinical

"Human chorionic gonadotrophin was given starting from a dose of 1000 up to 2000 UI twice a week with increments of 500 UI every 6 months and up-titrating the dose according to TTe levels (4, 17, 18)."

Provides the reported hCG component and biochemical titration strategy for the combined induction regimen.

Cardiac Surveillance

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Routine cardiac evaluation including echocardiogram and ECG to detect ventricular septal defects and conduction abnormalities (including Wolff-Parkinson-White-pattern pre-excitation), since these may be under-ascertained in classical clinical descriptions.

Target Phenotypes: Ventricular septal defect HP:0001629 Wolff-Parkinson-White syndrome HP:0001716

Show evidence (2 references)

PMID:30820409 SUPPORT Human Clinical

"Patients with TBX3 mutations should be evaluated for conduction block and ventricular preexcitation"

Directly recommends screening TBX3 carriers for both major conduction-system manifestations.

PMID:19938096 SUPPORT Human Clinical

"we suggest that clinicians caring for individuals with UMS offer brain imaging, growth hormone testing, and cardiac arrhythmia screening"

Independent UMS case-series recommendation supports cardiac arrhythmia surveillance.

🔬

Diagnosis

4

TBX3 Genetic Testing

Molecular confirmation of UMS via Sanger sequencing, gene panel, whole-exome, or whole-genome sequencing of TBX3, with variant classification under ACMG/AMP guidelines. Array-CGH should be considered when contiguous TBX3/TBX5 duplications or 12q24 deletions are suspected.

genetic testing NCIT:C15709

Show evidence (2 references)

PMID:36937985 SUPPORT Human Clinical

"Genomic exon detection was performed, and the results were verified by Sanger sequencing"

Recent case demonstrates exome sequencing with Sanger confirmation as the diagnostic workflow for TBX3-related UMS.

PMID:36140816 SUPPORT Human Clinical

"Next-generation sequencing revealed a novel, likely pathogenic, variant predicted to affect the canonical splice site in intron 3 of the TBX3 gene"

NGS-based detection of a TBX3 splice-site variant illustrates panel/exome sequencing diagnostic utility.

Pituitary MRI

Pituitary magnetic resonance imaging to detect anterior pituitary hypoplasia, thin pituitary stalk, and ectopic posterior pituitary, which are recurrent in UMS and underlie hypogonadotropic hypogonadism and growth hormone deficiency.

MRI of the brain NCIT:C16809

Show evidence (2 references)

PMID:40485890 SUPPORT Human Clinical

"Pituitary magnetic resonance imaging (MRI) revealed pituitary gland hypoplasia with a thin pituitary stalk and loss of a strong signal in the posterior pituitary"

MRI is the imaging modality that captures the structural pituitary phenotype underlying UMS endocrinopathy.

PMID:19938096 SUPPORT Human Clinical

"we suggest that clinicians caring for individuals with UMS offer brain imaging, growth hormone testing, and cardiac arrhythmia screening"

Clinical recommendation for routine brain imaging in UMS workup, motivated by under-ascertained pituitary findings.

Endocrine Workup (Gonadotropins, Growth Hormone, Sex Steroids)

Biochemical evaluation for hypogonadotropic hypogonadism (LH, FSH, testosterone or estradiol) and growth hormone axis (IGF-1, GH stimulation testing), recommended in patients with delayed puberty, short stature, or pituitary hypoplasia.

diagnostic procedure NCIT:C18020

Show evidence (1 reference)

PMID:19938096 SUPPORT Human Clinical

"we suggest that clinicians caring for individuals with UMS offer brain imaging, growth hormone testing, and cardiac arrhythmia screening"

Linden 2009 recommends growth hormone testing as part of a broader UMS clinical workup.

Cardiac Arrhythmia Screening (ECG and Echocardiography)

ECG and echocardiography to evaluate for ventricular septal defect, Wolff-Parkinson-White-pattern pre-excitation, and other conduction abnormalities, which may be under-ascertained in classical UMS descriptions.

electrocardiography NCIT:C38053

Show evidence (2 references)

PMID:30820409 SUPPORT Human Clinical

"Patients with TBX3 mutations should be evaluated for conduction block and ventricular preexcitation"

Direct clinical recommendation that TBX3 mutation carriers receive electrophysiological screening.

PMID:19938096 SUPPORT Human Clinical

"we suggest that clinicians caring for individuals with UMS offer brain imaging, growth hormone testing, and cardiac arrhythmia screening"

Linden 2009 explicitly recommends cardiac arrhythmia screening in UMS patients.

📊

Prevalence

1

Published literature worldwide

Cases In Literature Ultra Rare

No population-based prevalence estimate was identified for ulnar-mammary syndrome. Historical reports were rapidly superseded by a 1996 six-generation pedigree containing 33 affected relatives, so the entry does not convert literature case counts into a prevalence estimate.

Show evidence (2 references)

PMID:3621662 SUPPORT Human Clinical

"To date, another 12 patients in three families have been described with this syndrome."

Together with the four affected males in the family described in the same abstract, this establishes a historical literature count of 16 reported UMS patients in four families.

PMID:8923944 SUPPORT Human Clinical

"We present the clinical descriptions of 33 members of a six generation kindred with UMS. The number of affected individuals in this family is more than the sum of all previously reported cases of UMS."

Shows that even one large pedigree exceeded all earlier published cases, underscoring the syndrome's extreme rarity and the absence of population-based prevalence data.

🔀

Differential Diagnoses

1

Conditions with similar clinical presentations that must be differentiated from Ulnar-Mammary Syndrome:

Holt-Oram Syndrome MONDO:0007732

Overlapping Features TBX5-related Holt-Oram syndrome also combines upper-limb and cardiac findings, but classically affects anterior/radial limb structures rather than the posterior/ulnar structures of UMS; mammary, apocrine and genital findings favor TBX3-related disease.

Distinguishing Features

Posterior ulnar-ray deficiency in UMS versus anterior radial-ray deficiency in Holt-Oram syndrome
Mammary and axillary apocrine hypoplasia favor UMS
Causative TBX3 variant in UMS versus TBX5 variant in Holt-Oram syndrome

Show evidence (1 reference)

PMID:9207801 SUPPORT Human Clinical

"Limb abnormalities of ulnar-mammary syndrome involve posterior elements. Mutations in TBX5, a related and linked gene, cause anterior limb abnormalities in Holt-Oram syndrome."

Directly states the limb-pattern distinction between the two T-box disorders.

🐁

Animal Models

2

Heterozygous Tbx3 loss-of-function and mammary-development alleles Mus musculus

Mouse Tbx3 dosage models reproduce failure to maintain mammary placodes and reduced ductal branching, while developmental studies resolve the posterior limb-boundary mechanism. These models capture tissue-specific consequences of reduced Tbx3 dosage rather than the full variably expressed human syndrome.

Species

Mus musculus

Genotype

Heterozygous Tbx3 loss-of-function and mammary-development alleles

Genes

TBX3 hgnc:11602

Pathograph links

Posterior Limb Patterning Disruption Models TBX3-dependent positioning of the posterior boundary and SHH organizer territory.

Show evidence (1 reference)

PMID:38828908 SUPPORT Model Organism

"the posterior expression boundaries of anterior genes are positioned by TBX3-mediated repression, which excludes anterior genes such as Gli3, Alx4, Hand1 and Irx3/5 from the posterior limb bud mesenchyme"

Defines the posterior limb-boundary readout captured by the mouse model.

Apocrine Gland Development Failure Models the dosage-sensitive mammary placode and ductal branching defect.

Show evidence (1 reference)

PMID:16222716 SUPPORT Model Organism

"we show a haploinsufficiency effect of Tbx3 on maintenance of the mammary placodes and on the extent of branching of the ductal tree in mice"

Directly identifies the mammary developmental phenotype of reduced Tbx3 dosage.

Show evidence (1 reference)

PMID:16222716 SUPPORT Model Organism

"we show a haploinsufficiency effect of Tbx3 on maintenance of the mammary placodes and on the extent of branching of the ductal tree in mice"

Establishes an in-vivo dosage model for a central UMS developmental mechanism.

Humanized TBX3 model expressing p.P134S and comparison variants Drosophila melanogaster

A humanized fly system compares developmental effects of TBX3 variants in different protein regions. It supports pathogenicity and domain-level functional stratification, but does not reproduce the human organ-system phenotype.

Species

Drosophila melanogaster

Genotype

Humanized TBX3 model expressing p.P134S and comparison variants

Genes

TBX3 hgnc:11602

Pathograph links

TBX3 Haploinsufficiency Tests how disease-associated variants alter TBX3 activity and localization in a developmental context.

Show evidence (1 reference)

PMID:39320041 SUPPORT Model Organism

"Phenotypic analysis in flies, coupled with in silico modeling on the TBX3 variants, suggested that the c.400 C > T is UMS-causing and impacts TBX3 localization."

States the functional and localization readouts of the humanized model.

Show evidence (1 reference)

PMID:39320041 SUPPORT Model Organism

"we generated a Drosophila humanized model for TBX3 to study the developmental consequences of the p.P134S as well as of other variants targeting different regions of the protein."

Explicitly establishes the humanized fly model and its variant-comparison purpose.

{ }

Source YAML

click to show

name: Ulnar-Mammary Syndrome
synonyms:
- Ulnar-mammary syndrome, TBX3-related
creation_date: '2026-02-13T00:31:42Z'
category: Mendelian
description: >
  Ulnar-mammary syndrome (UMS; MIM  # 181450), also called Schinzel syndrome, is a
  rare autosomal dominant pleiotropic developmental disorder caused by heterozygous
  loss-of-function variants in TBX3, a T-box transcription factor that functions
  primarily as a transcriptional repressor. UMS affects posterior (ulnar) limb
  elements, apocrine gland development (breast/nipple and axillary glands), teeth,
  external genitalia, and the hypothalamic-pituitary axis (with hypogonadotropic
  hypogonadism and pituitary hypoplasia recurrent in both sexes). A subset of patients
  have congenital heart and conduction defects. TBX3 and the paralogous TBX5
  (mutated in Holt-Oram syndrome) evolved from a common ancestral T-box gene and
  acquired complementary roles in limb patterning, with TBX3 specifying posterior
  and TBX5 specifying anterior limb elements.
disease_term:
  preferred_term: ulnar-mammary syndrome
  term:
    id: MONDO:0008411
    label: ulnar-mammary syndrome
parents:
- Limb Development Disorders
inheritance:
- name: Autosomal Dominant
  description: >
    Autosomal dominant inheritance with marked
    intra- and interfamilial variable expressivity. TBX3 haploinsufficiency is
    the predominant pathogenic mechanism for most loss-of-function variants
    (frameshift, nonsense, splice-site), but mouse genetic studies indicate
    that some truncating alleles produce mislocalized proteins with phenotypes
    distinct from a true null, so not all UMS variants behave as simple nulls.
  evidence:
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Each mutation (a single nucleotide deletion and a splice-site \nmutation) is predicted to cause haploinsufficiency of TBX3, implying that \ncritical levels of this transcription factor are required for morphogenesis of \nseveral organs"
    explanation: "Demonstrates that TBX3 haploinsufficiency from heterozygous loss-of-function mutations is the pathogenic mechanism in autosomal dominant UMS."
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The clinical \nexpression of UMS is highly variable."
    explanation: Pallister kindred analysis directly establishes the marked variable expressivity that characterizes autosomal dominant TBX3-related disease.
  - reference: PMID:23844108
    reference_title: "Mouse TBX3 mutants suggest novel molecular mechanisms for Ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "not all \nmutations observed in humans generate functionally null alleles. The possibility \nthat mechanisms in addition to TBX3 haploinsufficiency may cause UMS or other \nmalformations merits investigation"
    explanation: Mouse Tbx3 mutant alleles show that some truncating variants produce mislocalized cytoplasmic protein with phenotypes distinct from true nulls, qualifying the simple haploinsufficiency model.
classifications:
  isds_skeletal_category:
  - classification_value: limb_hypoplasia_reduction_defects
    notes: >-
      ISDS Nosology and Classification of Genetic Skeletal Disorders, 2019 revision
      (Mortier et al., PMID:31633310), Table 1 group 39 "Limb hypoplasia-reduction
      defects group"; listed as "Ulnar-mammary syndrome".
prevalence:
- population: Published literature worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No population-based prevalence estimate was identified for ulnar-mammary
    syndrome. Historical reports were rapidly superseded by a 1996
    six-generation pedigree containing 33 affected relatives, so the entry does
    not convert literature case counts into a prevalence estimate.
  evidence:
  - reference: PMID:3621662
    reference_title: "The ulnar-mammary syndrome: an autosomal dominant pleiotropic gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To date, \nanother 12 patients in three families have been described with this syndrome."
    explanation: Together with the four affected males in the family described in the same abstract, this establishes a historical literature count of 16 reported UMS patients in four families.
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We present the clinical descriptions of 33 members of a six \ngeneration kindred with UMS. The number of affected individuals in this family \nis more than the sum of all previously reported cases of UMS."
    explanation: Shows that even one large pedigree exceeded all earlier published cases, underscoring the syndrome's extreme rarity and the absence of population-based prevalence data.
pathophysiology:
- name: TBX3 Haploinsufficiency
  description: >
    Heterozygous loss-of-function variants in TBX3 (a T-box DNA-binding
    transcriptional repressor on chromosome 12q24.21) reduce functional
    protein dosage below the level required for several developmental
    programs. Variants include frameshift, nonsense, splice-site, and
    missense changes both within and outside the T-box DNA-binding domain;
    missense variants in the T-box domain are functionally most disruptive,
    consistent with the genotype-phenotype trend that T-box-disrupting
    variants cause more severe limb and dental phenotypes. Mouse data
    indicate that some engineered truncating alleles produce cytoplasmically
    mislocalized protein, so a subset of human variants may act through
    mechanisms beyond simple loss of function. Reduced TBX3 dosage is the
    upstream lesion that converges on tissue-specific transcriptional
    programs in the limb bud, mammary placode, hypothalamic-pituitary axis,
    and cardiac conduction system.
  gene:
    preferred_term: TBX3
    term:
      id: hgnc:11602
      label: TBX3
  biological_processes:
  - preferred_term: Negative Regulation of Transcription by RNA Polymerase II
    term:
      id: GO:0000122
      label: negative regulation of transcription by RNA polymerase II
    modifier: DECREASED
  evidence:
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Each mutation (a single nucleotide deletion and a splice-site \nmutation) is predicted to cause haploinsufficiency of TBX3, implying that \ncritical levels of this transcription factor are required for morphogenesis of \nseveral organs"
    explanation: Original disease-gene paper demonstrating that heterozygous TBX3 loss-of-function variants cause UMS via haploinsufficiency.
  - reference: PMID:10330342
    reference_title: "The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Novel \nmutations have been found in all of eight newly reported families with UMS, \nincluding five mutations downstream of the region encoding the T-box"
    explanation: Establishes the breadth of the TBX3 mutation spectrum, including pathogenic variants outside the T-box DNA-binding domain.
  - reference: PMID:16530712
    reference_title: "Novel TBX3 mutation data in families with ulnar-mammary syndrome indicate a genotype-phenotype relationship: mutations that do not disrupt the T-domain are associated with less severe limb defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "an \nassociation between mutations that disrupt the DNA-binding domain and a higher \nfrequency of severe upper limb malformations and teeth defects"
    explanation: Demonstrates the genotype-phenotype gradient by which T-box-disrupting variants cause more severe limb and tooth phenotypes than non-T-box variants.
  - reference: PMID:39320041
    reference_title: "An inherited TBX3 alteration in a prenatal case of ulnar-mammary syndrome: Clinical assessment and functional characterization in Drosophila melanogaster."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "missense changes in the T-box \ndomain affect more significantly TBX3 activity than variants outside this \ndomain"
    explanation: Drosophila humanized model directly demonstrates that T-box-domain missense variants more severely impair TBX3 function than non-T-box variants, providing functional support for the genotype-phenotype trend.
  - reference: PMID:23844108
    reference_title: "Mouse TBX3 mutants suggest novel molecular mechanisms for Ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "a putative null \nallele in which exons 1-3 are deleted produces a truncated protein that is \nabnormally located in the cytoplasm. Heterozygotes and homozygotes for this \nallele have different phenotypes than their counterparts bearing a true null \nallele"
    explanation: Mouse Tbx3 alleles show that some truncating variants produce cytoplasmically mislocalized protein with phenotypes distinct from true nulls, supporting non-haploinsufficiency mechanisms for a subset of UMS variants.
  downstream:
  - target: Posterior Limb Patterning Disruption
    causal_link_type: DIRECT
    description: >
      Reduced TBX3 dosage in posterior limb bud mesenchyme fails to repress
      anterior gene boundaries, disrupting the anterior-posterior axis
      necessary for ulnar/posterior digit specification.
    evidence:
    - reference: PMID:38828908
      reference_title: "TBX3 is essential for establishment of the posterior boundary of anterior genes and upregulation of posterior genes together with HAND2 during the onset of limb bud development."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "the \nposterior expression boundaries of anterior genes are positioned by \nTBX3-mediated repression, which excludes anterior genes such as Gli3, Alx4, \nHand1 and Irx3/5 from the posterior limb bud mesenchyme. This exclusion \ndelineates the posterior mesenchymal territory competent to establish the \nShh-expressing limb bud organiser"
      explanation: Direct mouse evidence connects TBX3 activity to establishment of the posterior limb organizer.
  - target: Apocrine Gland Development Failure
    causal_link_type: DIRECT
    description: >
      Reduced TBX3 in mammary placode ectoderm fails to maintain placode
      identity and ductal branching, disrupting breast/nipple and apocrine
      gland morphogenesis.
    evidence:
    - reference: PMID:16222716
      reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "we show a haploinsufficiency effect of Tbx3 on maintenance of \nthe mammary placodes and on the extent of branching of the ductal tree in mice"
      explanation: Directly connects reduced Tbx3 dosage with impaired mammary placode maintenance and branching.
  - target: Hypothalamic-Pituitary Axis Disruption
    causal_link_type: DIRECT
    description: >
      Reduced TBX3 dosage during pituitary morphogenesis produces anterior
      pituitary hypoplasia (and ectopic posterior pituitary in some cases),
      manifesting clinically as hypogonadotropic hypogonadism and growth
      hormone deficiency.
    evidence:
    - reference: PMID:30550377
      reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the existence of congenital \nnormosmic IHH (nIHH) associated with pituitary hypoplasia in the two probands \nwho were heterozygous for novel TBX3 pathogenic variants"
      explanation: Human genotype-phenotype evidence supports the TBX3-to-pituitary axis while not claiming a fully resolved developmental route.
  - target: Cardiac Conduction System Disruption
    causal_link_type: DIRECT
    description: >
      Reduced TBX3 dosage in cardiac progenitors fails to specify the
      AV conduction system and to repress accessory AV pathways,
      producing conduction block and/or pre-excitation phenotypes.
    evidence:
    - reference: PMID:30820409
      reference_title: "Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "TBX3 both specifies the development of the normal atrioventricular conduction system and suppresses abnormal, accessory atrioventricular pathways elsewhere"
      explanation: Directly supports the TBX3-dependent conduction-system mechanism.
- name: Posterior Limb Patterning Disruption
  description: >
    During early limb-bud development, TBX3 establishes the posterior
    expression boundary of anterior identity genes by transcriptional
    repression that excludes Gli3, Alx4, Hand1, and Irx3/5 from the
    posterior limb bud mesenchyme. This exclusion delineates a posterior
    territory competent to establish the Sonic-hedgehog-expressing zone of
    polarizing activity (ZPA). HAND2 cooperates with TBX3 to upregulate
    shared posterior identity targets and is required for SHH activation.
    TBX3 is itself a direct transcriptional target of retinoic acid
    signaling via an RA-receptor complex bound to the TBX3 promoter,
    placing RA upstream of TBX3 in limb patterning. Haploinsufficiency
    disrupts posterior limb morphogenesis, causing ulnar ray defects
    ranging from fifth finger hypoplasia to complete ulnar absence;
    posterior digital duplications also occur. Limb defects of UMS
    specifically affect posterior elements, in mirror-image contrast to
    the anterior radial defects of TBX5-related Holt-Oram syndrome,
    reflecting the complementary roles acquired by these paralogues.
  cell_types:
  - preferred_term: Limb Bud Mesenchymal Cell
    term:
      id: CL:0008019
      label: mesenchymal cell
  biological_processes:
  - preferred_term: Embryonic Limb Morphogenesis
    term:
      id: GO:0030326
      label: embryonic limb morphogenesis
  - preferred_term: Anterior/Posterior Pattern Specification
    term:
      id: GO:0009952
      label: anterior/posterior pattern specification
  - preferred_term: Smoothened (SHH) Signaling Pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
    modifier: DECREASED
  - preferred_term: Retinoic Acid Receptor Signaling Pathway
    term:
      id: GO:0048384
      label: retinoic acid receptor signaling pathway
  evidence:
  - reference: PMID:38828908
    reference_title: "TBX3 is essential for establishment of the posterior boundary of anterior genes and upregulation of posterior genes together with HAND2 during the onset of limb bud development."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "the \nposterior expression boundaries of anterior genes are positioned by \nTBX3-mediated repression, which excludes anterior genes such as Gli3, Alx4, \nHand1 and Irx3/5 from the posterior limb bud mesenchyme. This exclusion \ndelineates the posterior mesenchymal territory competent to establish the \nShh-expressing limb bud organiser"
    explanation: Directly establishes the posterior boundary and organizer mechanism in mouse limb buds.
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Limb abnormalities of ulnar-mammary syndrome involve posterior \nelements"
    explanation: Human disease evidence anchors the posterior patterning mechanism to the characteristic limb distribution.
  - reference: PMID:22535523
    reference_title: "The ulnar-mammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "retinoic acid (RA) activates \nendogenous TBX3 expression, which is mediated by an RA-receptor complex directly \nbinding and activating the TBX3 promoter"
    explanation: Supports the upstream retinoic-acid component described for this node.
  downstream:
  - target: Ulnar Ray Deficiency
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Failed TBX3-mediated repression of Gli3/Alx4/Hand1/Irx3/5 in posterior mesenchyme
    - Failed TBX3-HAND2 co-activation of posterior identity genes
    - Reduced/mispositioned SHH expression at the ZPA
    - Failed posterior digit and ulna specification and outgrowth
    description: >
      Loss of TBX3-mediated posterior boundary specification disrupts
      establishment of the SHH organizer, producing the cardinal
      ulnar/posterior limb deficiency of UMS.
    evidence:
    - reference: PMID:38828908
      reference_title: "TBX3 is essential for establishment of the posterior boundary of anterior genes and upregulation of posterior genes together with HAND2 during the onset of limb bud development."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "the \nposterior expression boundaries of anterior genes are positioned by \nTBX3-mediated repression, which excludes anterior genes such as Gli3, Alx4, \nHand1 and Irx3/5 from the posterior limb bud mesenchyme. This exclusion \ndelineates the posterior mesenchymal territory competent to establish the \nShh-expressing limb bud organiser"
      explanation: Model evidence supports the organizer defect; the human ulnar phenotype is evidenced separately at the phenotype node.
- name: Apocrine Gland Development Failure
  description: >
    TBX3 is required for induction and maintenance of mammary placodes and
    for ductal branching morphogenesis of the breast and axillary apocrine
    glands. In mouse embryos, Wnt signaling and FGF8/FGFR1 signaling
    converge on the surface ectoderm to induce and maintain Tbx3 expression
    in the prospective mammary bud, where Tbx3 is the earliest known
    placodal marker (preceding Lef1). Haploinsufficiency reduces placode
    maintenance and ductal branching in mice, with a genetic interaction
    with Tbx2 that does not require the p19Arf/p53 pathway. In the adult
    mammary gland TBX3 is restricted to luminal hormone-sensing
    (estrogen-receptor-positive) cells and is required for generation of
    this lineage. Human UMS series group breast/nipple hypoplasia,
    diminished axillary perspiration, absent axillary hair, and hypohidrosis
    as the characteristic apocrine phenotype; axillary hair loss is retained
    as an association rather than assigned a specific causal route.
  cell_types:
  - preferred_term: Mammary Stem/Progenitor Cell
    term:
      id: CL:0002451
      label: mammary stem cell
  - preferred_term: Luminal Hormone-Sensing Mammary Cell
    term:
      id: CL:4033058
      label: luminal hormone-sensing cell of mammary gland
  - preferred_term: Apocrine Cell
    term:
      id: CL:0000033
      label: apocrine cell
  biological_processes:
  - preferred_term: Mammary Gland Development
    term:
      id: GO:0030879
      label: mammary gland development
    modifier: DECREASED
  - preferred_term: Mammary Placode Formation
    term:
      id: GO:0060596
      label: mammary placode formation
    modifier: DECREASED
  - preferred_term: Mammary Gland Morphogenesis
    term:
      id: GO:0060443
      label: mammary gland morphogenesis
    modifier: DECREASED
  - preferred_term: Wnt Signaling Pathway
    term:
      id: GO:0016055
      label: Wnt signaling pathway
  evidence:
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ulnar-mammary syndrome is a rare pleiotropic disorder affecting limb, apocrine \ngland, tooth and genital development"
    explanation: Establishes apocrine gland involvement (including breast) as a defining feature of UMS.
  - reference: PMID:15255957
    reference_title: "Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Tbx3 \nexpression is induced and maintained in early gland initiation by both Wnt and \nFgf signalling through FGFR1"
    explanation: Mouse embryo data place Wnt and FGFR1 signaling upstream of Tbx3 in mammary placode initiation, identifying the molecular cascade that fails in UMS apocrine hypoplasia.
  - reference: PMID:16222716
    reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we show a haploinsufficiency effect of Tbx3 on maintenance of \nthe mammary placodes and on the extent of branching of the ductal tree in mice"
    explanation: Direct mouse-genetic demonstration that Tbx3 haploinsufficiency impairs mammary placode maintenance and ductal branching - the developmental basis of UMS breast hypoplasia.
  - reference: PMID:16222716
    reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we find no \nevidence for involvement of these pathways either in embryonic lethality of \nhomozygous mutants or in the mammary gland phenotype of Tbx3 heterozygous mice"
    explanation: Excludes the p19Arf/p53 cell-cycle axis as the mediator of the mammary phenotype, confirming a TBX3-specific transcriptional program rather than generic proliferation arrest.
  - reference: PMID:25343378
    reference_title: "Transcriptional repressor Tbx3 is required for the hormone-sensing cell lineage in mammary epithelium."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Tbx3 is functionally relevant for this lineage because \nknockdown of Tbx3 in primary mammary epithelial cells prevented the formation of \nER+ cells"
    explanation: Identifies the luminal hormone-sensing (ER+) lineage as a TBX3-dependent compartment within the mammary epithelium, providing cellular specificity to the mammary phenotype.
  downstream:
  - target: Breast Hypoplasia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Failed Wnt/FGFR1-induced TBX3 expression in mammary placode ectoderm
    - Reduced mammary placode maintenance and ductal branching
    - Failed generation of luminal hormone-sensing (ER+) progenitors
    description: >
      Reduced TBX3 dosage during mammary placode formation and branching
      morphogenesis produces hypoplasia of the breast and nipple.
    evidence:
    - reference: PMID:16222716
      reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "we show a haploinsufficiency effect of Tbx3 on maintenance of \nthe mammary placodes and on the extent of branching of the ductal tree in mice"
      explanation: Tbx3 haploinsufficiency directly impairs the placode and ductal processes underlying breast hypoplasia.
  - target: Hypoplastic Nipples
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Reduced mammary placode maintenance
    description: >-
      The dosage-sensitive mammary placode defect provides a supported
      developmental route to hypoplastic nipples and areolae.
    evidence:
    - reference: PMID:16222716
      reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "we show a haploinsufficiency effect of Tbx3 on maintenance of \nthe mammary placodes and on the extent of branching of the ductal tree in mice"
      explanation: The mouse model directly supports impaired placode maintenance; the human nipple phenotype is separately evidenced at its phenotype node.
  - target: Hypohidrosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Human clinical series classify diminished or absent axillary
      perspiration within the apocrine-gland abnormality spectrum, although
      the intervening developmental steps are not resolved.
    evidence:
    - reference: PMID:8923944
      reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Apocrine gland abnormalities \nrange from diminished axillary perspiration with normal breast development and \nlactation, to complete absence of the breasts and no axillary perspiration"
      explanation: Directly places diminished or absent axillary perspiration in the human apocrine-gland phenotype spectrum.
- name: Hypothalamic-Pituitary Axis Disruption
  description: >
    TBX3 is expressed in the developing pituitary gland, and recurrent
    structural pituitary findings in UMS - anterior pituitary hypoplasia,
    thin pituitary stalk, and ectopic posterior pituitary - implicate
    TBX3 dosage in adenohypophysis development. The clinical consequence
    is congenital normosmic hypogonadotropic hypogonadism (often
    persistent into adulthood), partial growth hormone deficiency, and
    short stature; a combined-cohort analysis found delayed puberty in
    79% of UMS males and other signs of hypogonadism in 37%. The
    endocrine phenotype can be the presenting (or only) feature, even
    without overt limb or mammary signs, so TBX3 belongs in the
    diagnostic differential for congenital nIHH with midline defects.
  cell_types:
  - preferred_term: Gonadotroph
    term:
      id: CL:0000437
      label: gonadtroph
  - preferred_term: Somatotroph
    term:
      id: CL:0002312
      label: somatotroph
  biological_processes:
  - preferred_term: Adenohypophysis Development
    term:
      id: GO:0021984
      label: adenohypophysis development
    modifier: DECREASED
  - preferred_term: Pituitary Gland Development
    term:
      id: GO:0021983
      label: pituitary gland development
    modifier: DECREASED
  evidence:
  - reference: PMID:30550377
    reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the existence of congenital \nnormosmic IHH (nIHH) associated with pituitary hypoplasia in the two probands \nwho were heterozygous for novel TBX3 pathogenic variants"
    explanation: Direct clinical demonstration that TBX3 pathogenic variants cause congenital normosmic hypogonadotropic hypogonadism with pituitary hypoplasia.
  - reference: PMID:30550377
    reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "delayed puberty and other signs of hypogonadism \nin 79 and 37% of UMS males, respectively"
    explanation: Provides population-level frequency estimates anchoring the hypogonadotropic-hypogonadism phenotype in UMS males.
  - reference: PMID:30550377
    reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "TBX3 should be included among candidate genes for \ncongenital nIHH"
    explanation: Establishes TBX3 as a candidate gene for isolated congenital normosmic IHH, beyond classic UMS diagnostic settings.
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a hypoplastic \nanterior pituitary and an ectopic posterior pituitary gland"
    explanation: Documents anterior pituitary hypoplasia and ectopic posterior pituitary as TBX3-related structural pituitary anomalies.
  - reference: PMID:40485890
    reference_title: "Clinical and genetic analysis of ulnar-mammary syndrome caused by a novel TBX3 mutation in a Chinese boy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pituitary magnetic \nresonance imaging (MRI) revealed pituitary gland hypoplasia with a thin \npituitary stalk and loss of a strong signal in the posterior pituitary"
    explanation: Recent case adds imaging-confirmed pituitary hypoplasia and posterior pituitary signal loss to the structural endocrine phenotype.
  - reference: PMID:40995837
    reference_title: "TBX3- Related Disorder."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "More recent \nstudies identified a high rate of pituitary hypoplasia with decreased levels of \ngonadotropins and growth hormone in both males and females, in some cases as an \nisolated finding"
    explanation: Recent (2026) review frames pituitary hypoplasia with combined gonadotropin and growth-hormone deficiency as a recurrent, sometimes isolated feature of TBX3-related disorder.
  downstream:
  - target: Hypogonadotropic Hypogonadism
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Anterior pituitary (gonadotroph) hypoplasia
    - Reduced LH/FSH secretion
    description: >
      Gonadotroph hypoplasia produces inadequate LH/FSH drive of the
      gonadal axis, manifesting as nIHH and delayed/absent puberty.
    evidence:
    - reference: PMID:30550377
      reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "delayed puberty due to normosmic hypogonadotropic hypogonadism with pituitary hypoplasia is a recurrent feature"
      explanation: Directly links the pituitary phenotype with hypogonadotropic hypogonadism and delayed puberty.
  - target: Anterior Pituitary Hypoplasia
    causal_link_type: DIRECT
    description: >
      Reduced TBX3 dosage in pituitary anlage produces anatomic
      anterior pituitary hypoplasia on MRI.
    evidence:
    - reference: PMID:30550377
      reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "TBX3 knockout causes a failure in the infundibulum development, resulting in Rathke’s pouch degeneration and pituitary hypoplasia"
      explanation: Mouse knockout evidence directly supports the developmental route to pituitary hypoplasia.
  - target: Growth Hormone Deficiency
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Anterior pituitary (somatotroph) hypoplasia
    description: >
      Somatotroph dysfunction in the hypoplastic anterior pituitary
      reduces GH secretion, contributing to short stature.
    evidence:
    - reference: PMID:40995837
      reference_title: "TBX3- Related Disorder."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "a high rate of pituitary hypoplasia with decreased levels of \ngonadotropins and growth hormone in both males and females"
      explanation: Narrative synthesis supports the association between pituitary hypoplasia and reduced growth hormone.
  - target: Short Stature
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - GH deficiency from anterior pituitary hypoplasia
    - Delayed pubertal growth from hypogonadotropic hypogonadism
    description: >
      Combined GH deficiency and pubertal delay produce short stature
      that can respond to recombinant human GH and gonadotropin therapy.
    evidence:
    - reference: PMID:19938096
      reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "short stature with associated growth \nhormone deficiency"
      explanation: Human evidence supports GH deficiency as one contributor to short stature without asserting it explains every case.
  - target: Delayed Puberty
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Hypogonadotropic hypogonadism with reduced LH/FSH drive
    description: >
      Reduced gonadotropin output delays or prevents pubertal onset,
      especially in males.
    evidence:
    - reference: PMID:30550377
      reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "delayed puberty due to normosmic hypogonadotropic hypogonadism with pituitary hypoplasia is a recurrent feature"
      explanation: Directly supports delayed puberty downstream of the hypogonadotropic pituitary phenotype.
- name: Cardiac Conduction System Disruption
  description: >
    TBX3 plays a dichotomous role in patterning the atrioventricular (AV)
    conduction system: it specifies the development of the normal AV
    conduction tissue (AV node, His bundle, bundle branches) and represses
    the formation of accessory AV pathways elsewhere in working myocardium.
    Haploinsufficiency therefore produces a bidirectional electrical
    phenotype - conduction block from inadequate AV-node/Purkinje
    specification, and ventricular pre-excitation (Wolff-Parkinson-White
    pattern) from failure to suppress accessory pathways. TBX3 may also
    maintain postnatal conduction-system health, supporting adult-onset
    sinus-node dysfunction and AV block in carriers.
  biological_processes:
  - preferred_term: Cardiac Conduction System Development
    term:
      id: GO:0003161
      label: cardiac conduction system development
    modifier: DECREASED
  evidence:
  - reference: PMID:30820409
    reference_title: "Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "TBX3 both specifies the development of the normal atrioventricular conduction system and suppresses abnormal, accessory atrioventricular pathways elsewhere"
    explanation: Defines the dichotomous TBX3 role - specifying normal AV conduction tissue and repressing accessory pathways - that explains both conduction block and pre-excitation phenotypes in UMS.
  - reference: PMID:30820409
    reference_title: "Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients with TBX3 mutations should be evaluated for conduction block and ventricular preexcitation"
    explanation: Direct clinical recommendation that TBX3 carriers be screened for both conduction block and pre-excitation, supporting cardiac surveillance.
  - reference: PMID:30820409
    reference_title: "Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients with TBX3 mutations should be followed for the possibility of developing adult-onset conduction disease"
    explanation: Establishes a postnatal-maintenance role for TBX3 in conduction-system health, motivating long-term electrophysiologic follow-up.
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cardiac conduction defects consistent with \nWolff-Parkinson-White (WPW) syndrome"
    explanation: Clinical UMS case documents WPW-pattern conduction defects in a TBX3-mutation-confirmed patient.
  downstream:
  - target: Cardiac Conduction Abnormality
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - Failed TBX3-driven specification of AV conduction-system myocardium
    - Failed TBX3-mediated repression of accessory AV pathways in working myocardium
    description: >
      TBX3 dosage is required both to specify normal conduction tissue and
      to suppress accessory pathways; loss produces WPW-pattern pre-excitation
      and/or conduction block.
    evidence:
    - reference: PMID:30820409
      reference_title: "Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "a de novo loss-of-function mutation of TBX3 is associated with ventricular preexcitation and proximal right bundle branch block"
      explanation: A human loss-of-function case directly connects TBX3 disruption to conduction abnormalities.
phenotypes:
- name: Ulnar Ray Deficiency
  description: >
    Posterior (ulnar) upper limb defects ranging from hypoplasia of the
    terminal phalanx of the fifth digit through fifth-finger and ulnar
    hypoplasia to complete absence of the ulna and the third, fourth, and
    fifth digits. Limb abnormalities specifically involve posterior
    elements, in mirror-image contrast to the anterior radial defects of
    Holt-Oram syndrome.
  category: Skeletal
  phenotype_term:
    preferred_term: Hypoplasia of the ulna
    term:
      id: HP:0003022
      label: Hypoplasia of the ulna
  evidence:
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Limb abnormalities of ulnar-mammary syndrome involve posterior \nelements"
    explanation: Confirms that UMS limb defects specifically affect posterior (ulnar) structures.
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the range of abnormalities extends from hypoplasia of the terminal \nphalanx of the 5th digit to complete absence of the ulna and 3rd, 4th, and 5th \ndigits"
    explanation: Pallister kindred analysis documents the full clinical spectrum of posterior limb deficiency in UMS.
  - reference: PMID:16530712
    reference_title: "Novel TBX3 mutation data in families with ulnar-mammary syndrome indicate a genotype-phenotype relationship: mutations that do not disrupt the T-domain are associated with less severe limb defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "an \nassociation between mutations that disrupt the DNA-binding domain and a higher \nfrequency of severe upper limb malformations"
    explanation: T-box-domain genotype-phenotype gradient applies most strongly to limb severity.
- name: Breast Hypoplasia
  description: >
    Hypoplasia or aplasia of breast tissue, ranging from diminished
    development with normal lactation to complete absence of the breasts,
    reflecting failed mammary placode maintenance and ductal branching.
    This is a hallmark feature of UMS, distinguishing it from other
    posterior limb malformation syndromes.
  category: Apocrine
  phenotype_term:
    preferred_term: Breast hypoplasia
    term:
      id: HP:0003187
      label: Breast hypoplasia
  evidence:
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ulnar-mammary syndrome is a rare pleiotropic disorder affecting limb, apocrine \ngland, tooth and genital development"
    explanation: Apocrine/mammary gland involvement is a defining feature of UMS.
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Apocrine gland abnormalities \nrange from diminished axillary perspiration with normal breast development and \nlactation, to complete absence of the breasts and no axillary perspiration"
    explanation: Pallister kindred analysis documents the spectrum of breast hypoplasia/aplasia in UMS.
  - reference: PMID:16222716
    reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we show a haploinsufficiency effect of Tbx3 on maintenance of \nthe mammary placodes and on the extent of branching of the ductal tree in mice"
    explanation: Mouse-genetic basis for the human breast hypoplasia phenotype - Tbx3 dosage controls mammary placode maintenance and ductal branching.
- name: Absent Axillary Hair
  description: >
    Absent or sparse axillary hair, reflecting failure of axillary
    apocrine gland development. A characteristic apocrine sign of UMS in
    both sexes.
  category: Apocrine
  phenotype_term:
    preferred_term: Absent axillary hair
    term:
      id: HP:0002221
      label: Absent axillary hair
  evidence:
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "both sexes have diminished to absent \naxillary hair"
    explanation: Pallister kindred clinical analysis documents diminished or absent axillary hair as a consistent UMS feature in both sexes.
  - reference: PMID:16530712
    reference_title: "Novel TBX3 mutation data in families with ulnar-mammary syndrome indicate a genotype-phenotype relationship: mutations that do not disrupt the T-domain are associated with less severe limb defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "typical \nUMS traits (hypoplasia of the breast and axillary hair, upper limbs and genital \ndefects)"
    explanation: Absent axillary hair is listed among typical UMS features.
- name: Delayed Puberty
  description: >
    Delayed or absent onset of puberty, especially in males, secondary to
    persistent hypogonadotropic hypogonadism. A combined-cohort analysis
    identified delayed puberty in 79% of UMS males. The HH-related deficit
    is stable rather than progressive (puberty fails to start and remains
    absent without exogenous gonadotropin/testosterone replacement).
  category: Endocrine
  phenotype_term:
    preferred_term: Delayed puberty
    term:
      id: HP:0000823
      label: Delayed puberty
    clinical_course: STABLE
  evidence:
  - reference: PMID:30550377
    reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "delayed puberty and other signs of hypogonadism \nin 79 and 37% of UMS males, respectively"
    explanation: Provides cohort-level frequency of delayed puberty in UMS males, anchoring this as a high-frequency phenotype.
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected males \nconsistently undergo delayed puberty"
    explanation: Pallister kindred clinical analysis supports consistent delayed puberty in affected males.
- name: Postaxial Hand Polydactyly
  description: >
    Posterior (ulnar-side) digital duplications, including fifth-finger
    duplications and postaxial polydactyly. Posterior digital duplications
    can co-occur with contralateral ulnar deficiency, reflecting disturbed
    rather than purely deficient posterior patterning.
  category: Skeletal
  phenotype_term:
    preferred_term: Postaxial hand polydactyly
    term:
      id: HP:0001162
      label: Postaxial hand polydactyly
  evidence:
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "affected individuals may have posterior digital duplications \nwith or without contralateral limb deficiencies"
    explanation: Pallister kindred documents posterior digital duplications as part of the UMS limb spectrum.
  - reference: PMID:36140816
    reference_title: "TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a one-year-old female with \nunilateral, postaxial polydactyly, and bilateral fifth fingernail duplication"
    explanation: Modern case report documents postaxial polydactyly with TBX3 splice-site variant.
- name: Hypoplastic Nipples
  description: >
    Hypoplasia, retraction, or inversion of the nipples and reduced
    areolar development, reflecting disrupted mammary placode/nipple
    morphogenesis. Hypoplastic or absent nipples are core prepubertal
    recognition features of UMS.
  category: Apocrine
  phenotype_term:
    preferred_term: Hypoplastic nipples
    term:
      id: HP:0002557
      label: Hypoplastic nipples
  evidence:
  - reference: PMID:39320041
    reference_title: "An inherited TBX3 alteration in a prenatal case of ulnar-mammary syndrome: Clinical assessment and functional characterization in Drosophila melanogaster."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Core features often \npresent pre-pubertally include defects of the ulna and/or of ulnar ray, \nhypoplastic nipples and/or areolas"
    explanation: 2024 review/cohort analysis explicitly anchors hypoplastic nipples/areolas as a core prepubertal UMS feature.
  - reference: PMID:36937985
    reference_title: "Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "short stature, ulnar \nhypoplasia of the forearm, hypohidrosis, retracted nipple"
    explanation: Recent case shows retracted nipple as an apocrine clinical readout in a TBX3-mutation-confirmed UMS proband.
- name: Hypohidrosis
  description: >
    Reduced sweating, especially in the axillae, secondary to apocrine
    sweat gland hypoplasia. Reduced perspiration is a classical apocrine
    sign of UMS.
  category: Apocrine
  phenotype_term:
    preferred_term: Hypohidrosis
    term:
      id: HP:0000966
      label: Hypohidrosis
  evidence:
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Apocrine gland abnormalities \nrange from diminished axillary perspiration with normal breast development and \nlactation, to complete absence of the breasts and no axillary perspiration"
    explanation: Pallister kindred clinical description documents diminished/absent axillary perspiration as part of the apocrine UMS phenotype.
  - reference: PMID:36937985
    reference_title: "Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "short stature, ulnar \nhypoplasia of the forearm, hypohidrosis"
    explanation: Recent case shows hypohidrosis in a TBX3-mutation-confirmed UMS proband.
- name: Hypogonadotropic Hypogonadism
  description: >
    Congenital normosmic hypogonadotropic hypogonadism (nIHH) with
    inadequate LH/FSH secretion, often persistent into adulthood and
    associated with anterior pituitary hypoplasia. Endocrine signs may be
    the presenting feature even without overt limb or mammary phenotypes.
  category: Endocrine
  phenotype_term:
    preferred_term: Hypogonadotropic hypogonadism
    term:
      id: HP:0000044
      label: Hypogonadotropic hypogonadism
  evidence:
  - reference: PMID:30550377
    reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the existence of congenital \nnormosmic IHH (nIHH) associated with pituitary hypoplasia in the two probands \nwho were heterozygous for novel TBX3 pathogenic variants"
    explanation: Direct clinical demonstration of congenital nIHH co-segregating with TBX3 pathogenic variants and pituitary hypoplasia.
  - reference: PMID:39788453
    reference_title: "A family with an atypical presentation of TBX3-related disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Endocrine abnormalities include \nhypogonadotropic hypogonadism (HH), partial growth hormone deficiency"
    explanation: Recent family report frames hypogonadotropic hypogonadism and GH deficiency as canonical TBX3-related endocrine findings.
- name: Anterior Pituitary Hypoplasia
  description: >
    Anatomic hypoplasia of the anterior pituitary on MRI, often with thin
    pituitary stalk and (in some cases) ectopic posterior pituitary,
    underlying the combined gonadotropin and growth-hormone deficiencies.
  category: Endocrine
  phenotype_term:
    preferred_term: Anterior pituitary hypoplasia
    term:
      id: HP:0010627
      label: Anterior pituitary hypoplasia
  evidence:
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a hypoplastic \nanterior pituitary and an ectopic posterior pituitary gland"
    explanation: Documents anterior pituitary hypoplasia and ectopic posterior pituitary as TBX3-related structural pituitary anomalies.
  - reference: PMID:40485890
    reference_title: "Clinical and genetic analysis of ulnar-mammary syndrome caused by a novel TBX3 mutation in a Chinese boy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "pituitary gland hypoplasia with a thin \npituitary stalk and loss of a strong signal in the posterior pituitary"
    explanation: Recent case provides MRI-confirmed pituitary hypoplasia with thin stalk and posterior pituitary signal loss.
- name: Growth Hormone Deficiency
  description: >
    Partial growth hormone deficiency secondary to anterior pituitary
    hypoplasia, often responsive to recombinant human growth hormone
    therapy.
  category: Endocrine
  phenotype_term:
    preferred_term: Growth hormone deficiency
    term:
      id: HP:0008240
      label: Secondary growth hormone deficiency
  evidence:
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "short stature with associated growth \nhormone deficiency"
    explanation: Documents growth hormone deficiency as part of the UMS endocrine phenotype.
  - reference: PMID:36937985
    reference_title: "Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Laboratory examination revealed hyperthyroidism, growth hormone \ndeficiency, and hypogonadotropic hypogonadism"
    explanation: Recent case confirms growth hormone deficiency in a TBX3-mutation-confirmed proband.
- name: Short Stature
  description: >
    Short stature can accompany growth hormone deficiency and delayed
    pubertal growth in UMS and may respond to recombinant human growth
    hormone therapy. No frequency is assigned because the cached evidence
    does not provide a denominator-based estimate.
  category: Growth
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "bilateral ulnar defects, inverted nipples, short stature with associated growth \nhormone deficiency"
    explanation: Documents short stature as a feature of TBX3-mutation-confirmed UMS.
  - reference: PMID:36748390
    reference_title: "Ulnar-Mammary syndrome with TBX3 gene mutation in a Chinese family: A case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The proband then was treated with recombinant human growth hormone (rhGH)
      and human chorionic gonadotropin (hCG). After a year and a half, his height
      and secondary sexual characteristics were significantly improved.
    explanation: Modern Chinese family report demonstrates that short stature in UMS responds to rhGH/hCG, anchoring the endocrine basis of the growth phenotype.
- name: Micropenis
  description: >
    Micropenis from inadequate fetal/neonatal androgen exposure
    secondary to hypogonadotropic hypogonadism. Frequently co-occurs
    with cryptorchidism in UMS males.
  category: Genital
  phenotype_term:
    preferred_term: Micropenis
    term:
      id: HP:0000054
      label: Micropenis
  evidence:
  - reference: PMID:36937985
    reference_title: "Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "retracted nipple, micropenis, and \ncryptorchidism"
    explanation: Recent case documents micropenis with cryptorchidism in a TBX3-mutation-confirmed proband.
  - reference: PMID:39788453
    reference_title: "A family with an atypical presentation of TBX3-related disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "twin siblings with micropenis, \nneonatal hypogonadism, and congenital giant bladder diverticula"
    explanation: Recent family report documents micropenis with neonatal hypogonadism in TBX3-mutation-positive twins.
- name: Cryptorchidism
  description: >
    Undescended testes from inadequate gonadotropin/testosterone drive
    during fetal testicular descent.
  category: Genital
  phenotype_term:
    preferred_term: Cryptorchidism
    term:
      id: HP:0000028
      label: Cryptorchidism
  evidence:
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "short stature with associated growth \nhormone deficiency, and cryptorchidism"
    explanation: Documents cryptorchidism in a TBX3-mutation-confirmed UMS patient.
- name: Ventricular Septal Defect
  description: >
    Ventricular septal defect has been reported in molecularly confirmed
    UMS, but the retained evidence does not establish a specific septation
    mechanism.
  category: Cardiac
  phenotype_term:
    preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  evidence:
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ventricular septal \ndefect (VSD), and cardiac conduction defects consistent with \nWolff-Parkinson-White (WPW) syndrome"
    explanation: Documents VSD with WPW-pattern conduction defects in TBX3-mutation-confirmed UMS.
- name: Cardiac Conduction Abnormality
  description: >
    Conduction-system defects, including Wolff-Parkinson-White-pattern
    pre-excitation, reflecting the developmental role of TBX3 in cardiac
    conduction-system specification.
  category: Cardiac
  phenotype_term:
    preferred_term: Wolff-Parkinson-White syndrome
    term:
      id: HP:0001716
      label: Wolff-Parkinson-White syndrome
  evidence:
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cardiac conduction defects consistent with \nWolff-Parkinson-White (WPW) syndrome"
    explanation: Documents WPW-pattern conduction defect in TBX3-mutation-confirmed UMS, supporting cardiac surveillance recommendations.
- name: Hypodontia
  description: >
    Missing or malformed teeth, including misplaced canines, reflecting
    TBX3 dosage requirement during odontogenesis. Dental anomalies are
    more frequent in patients with T-box-disrupting variants.
  category: Dental
  phenotype_term:
    preferred_term: Hypodontia
    term:
      id: HP:0000668
      label: Hypodontia
  evidence:
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dental abnormalities include misplaced or absent teeth"
    explanation: Pallister kindred analysis documents dental abnormalities including hypodontia.
  - reference: PMID:16530712
    reference_title: "Novel TBX3 mutation data in families with ulnar-mammary syndrome indicate a genotype-phenotype relationship: mutations that do not disrupt the T-domain are associated with less severe limb defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "an \nassociation between mutations that disrupt the DNA-binding domain and a higher \nfrequency of severe upper limb malformations and teeth defects"
    explanation: Confirms genotype-phenotype gradient that places dental defects with T-box-disrupting variants.
- name: Bifid Nasal Tip
  description: >
    Midline craniofacial anomaly with a bifid nasal tip, recognized as a
    typical UMS feature even in patients lacking obvious limb or mammary
    involvement.
  category: Craniofacial
  phenotype_term:
    preferred_term: Bifid nasal tip
    term:
      id: HP:0000456
      label: Bifid nasal tip
  evidence:
  - reference: PMID:39788453
    reference_title: "A family with an atypical presentation of TBX3-related disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The physical examination revealed a bifid nasal tip and a \nbi-lobulated tongue tip typical for UMS"
    explanation: Recent family report establishes bifid nasal tip as a recognizable UMS feature in atypical presentations.
- name: Bifid Tongue
  description: >
    Bilobed/bifid tongue tip from incomplete midline fusion of the
    lateral lingual swellings, reported as a typical UMS feature.
  category: Craniofacial
  phenotype_term:
    preferred_term: Bifid tongue
    term:
      id: HP:0010297
      label: Bifid tongue
  evidence:
  - reference: PMID:39788453
    reference_title: "A family with an atypical presentation of TBX3-related disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a bifid nasal tip and a \nbi-lobulated tongue tip typical for UMS with no apparent limb or mammary \ndefects"
    explanation: Documents bilobed tongue tip as a typical UMS midline feature.
- name: Imperforate Hymen
  description: >
    Imperforate hymen has been reported in some affected females within
    classical UMS kindreds, expanding the genitourinary phenotype beyond
    male-predominant findings.
  category: Genital
  phenotype_term:
    preferred_term: Imperforate hymen
    term:
      id: HP:0030011
      label: Imperforate hymen
  evidence:
  - reference: PMID:8923944
    reference_title: "Clinical analysis of a large kindred with the Pallister ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Imperforate hymen were seen in some affected women"
    explanation: Pallister kindred clinical analysis documents imperforate hymen in some affected females.
- name: Bladder Diverticulum
  description: >
    Congenital bladder diverticula reported in TBX3-mutation-positive
    siblings, expanding the genitourinary phenotypic spectrum of
    TBX3-related disorder.
  category: Genitourinary
  phenotype_term:
    preferred_term: Bladder diverticulum
    term:
      id: HP:0000015
      label: Bladder diverticulum
  evidence:
  - reference: PMID:39788453
    reference_title: "A family with an atypical presentation of TBX3-related disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "twin siblings with micropenis, \nneonatal hypogonadism, and congenital giant bladder diverticula"
    explanation: Documents congenital bladder diverticula in TBX3-mutation-positive twins, extending the genitourinary phenotype.
genetic:
- name: TBX3
  presence: Positive
  association: Causative
  gene_term:
    preferred_term: TBX3
    term:
      id: hgnc:11602
      label: TBX3
  notes: >
    Heterozygous pathogenic variants in TBX3 (12q24.21) cause ulnar-mammary
    syndrome. Variant classes include frameshift, nonsense, splice-site,
    and missense changes both within and outside the T-box DNA-binding
    domain; downstream-of-T-box variants are also pathogenic, indicating
    that conserved domains outside the T-box are functionally important.
    Mutation type alone does not strongly predict severity, but T-box
    domain-disrupting variants are associated with more severe upper limb
    and dental phenotypes than non-T-box variants. Functional analysis in
    a humanized Drosophila model corroborates that missense changes in the
    T-box domain impair TBX3 activity more severely than non-T-box
    variants. Mouse genetics indicate that some truncating alleles produce
    cytoplasmically mislocalized protein with phenotypes distinct from a
    true null, qualifying the simple haploinsufficiency model. Reported
    representative variants include c.1121_1124delAGAG (p.Glu374fs)
    frameshift, c.804+1G>A canonical splice variant, c.400C>T (p.P134S)
    T-box missense (absent from gnomAD), and the TBX3/TBX5 contiguous
    duplication producing an overlapping HOS/UMS phenotype.
  evidence:
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "mutations in human \nTBX3, a member of the T-box gene family, cause ulnar-mammary syndrome"
    explanation: Original disease-gene paper establishes TBX3 as the causative gene for UMS.
  - reference: PMID:10330342
    reference_title: "The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Novel \nmutations have been found in all of eight newly reported families with UMS, \nincluding five mutations downstream of the region encoding the T-box"
    explanation: Demonstrates the breadth of the TBX3 mutation spectrum, including pathogenic variants outside the T-box DNA-binding domain.
  - reference: PMID:10330342
    reference_title: "The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found no obvious phenotypic differences between \nthose who have missense mutations and those who have deletions or frameshifts"
    explanation: Indicates that mutation type alone does not strongly predict phenotypic severity.
  - reference: PMID:16530712
    reference_title: "Novel TBX3 mutation data in families with ulnar-mammary syndrome indicate a genotype-phenotype relationship: mutations that do not disrupt the T-domain are associated with less severe limb defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "mutations that do not disrupt the T-domain are associated with less severe limb defects"
    explanation: Refines the genotype-phenotype picture - T-domain disrupting variants cause more severe limb involvement.
  - reference: PMID:39320041
    reference_title: "An inherited TBX3 alteration in a prenatal case of ulnar-mammary syndrome: Clinical assessment and functional characterization in Drosophila melanogaster."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "missense changes in the T-box \ndomain affect more significantly TBX3 activity than variants outside this \ndomain"
    explanation: Drosophila humanized model gives functional support to the T-box-domain genotype-phenotype gradient.
  - reference: PMID:33930582
    reference_title: "TBX3 and TBX5 duplication: A family with an atypical overlapping Holt-Oram/ulnar-mammary syndrome phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report on a large German family with at least 17 affected \nindividuals over 6 generations bearing a duplication at 12q24.21 identified on \narray-CGH comprising both TBX5 and TBX3 genes"
    explanation: Documents a contiguous TBX3/TBX5 duplication producing an overlapping Holt-Oram/ulnar-mammary phenotype, expanding the variant spectrum beyond simple loss-of-function.
  - reference: CGGV:assertion_e2da7f67-a3d6-4e11-a71b-d8923771bf8c-2025-04-22T160000.000Z
    reference_title: "TBX3 / ulnar-mammary syndrome (Definitive)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "TBX3 | HGNC:11602 | ulnar-mammary syndrome | MONDO:0008411 | AD | Definitive"
    explanation: ClinGen classifies the TBX3-ulnar-mammary syndrome gene-disease relationship as definitive with autosomal dominant inheritance.
diagnosis:
- name: TBX3 Genetic Testing
  description: >
    Molecular confirmation of UMS via Sanger sequencing, gene panel,
    whole-exome, or whole-genome sequencing of TBX3, with variant
    classification under ACMG/AMP guidelines. Array-CGH should be
    considered when contiguous TBX3/TBX5 duplications or 12q24
    deletions are suspected.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:36937985
    reference_title: "Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Genomic \nexon detection was performed, and the results were verified by Sanger \nsequencing"
    explanation: Recent case demonstrates exome sequencing with Sanger confirmation as the diagnostic workflow for TBX3-related UMS.
  - reference: PMID:36140816
    reference_title: "TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next-generation sequencing revealed a novel, likely pathogenic, variant \npredicted to affect the canonical splice site in intron 3 of the TBX3 gene"
    explanation: NGS-based detection of a TBX3 splice-site variant illustrates panel/exome sequencing diagnostic utility.
- name: Pituitary MRI
  description: >
    Pituitary magnetic resonance imaging to detect anterior pituitary
    hypoplasia, thin pituitary stalk, and ectopic posterior pituitary,
    which are recurrent in UMS and underlie hypogonadotropic hypogonadism
    and growth hormone deficiency.
  diagnosis_term:
    preferred_term: MRI of the brain
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: PMID:40485890
    reference_title: "Clinical and genetic analysis of ulnar-mammary syndrome caused by a novel TBX3 mutation in a Chinese boy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pituitary magnetic \nresonance imaging (MRI) revealed pituitary gland hypoplasia with a thin \npituitary stalk and loss of a strong signal in the posterior pituitary"
    explanation: MRI is the imaging modality that captures the structural pituitary phenotype underlying UMS endocrinopathy.
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we suggest that clinicians caring for individuals with \nUMS offer brain imaging, growth hormone testing, and cardiac arrhythmia \nscreening"
    explanation: Clinical recommendation for routine brain imaging in UMS workup, motivated by under-ascertained pituitary findings.
- name: Endocrine Workup (Gonadotropins, Growth Hormone, Sex Steroids)
  description: >
    Biochemical evaluation for hypogonadotropic hypogonadism (LH, FSH,
    testosterone or estradiol) and growth hormone axis (IGF-1, GH
    stimulation testing), recommended in patients with delayed puberty,
    short stature, or pituitary hypoplasia.
  diagnosis_term:
    preferred_term: diagnostic procedure
    term:
      id: NCIT:C18020
      label: Diagnostic Procedure
  evidence:
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we suggest that clinicians caring for individuals with UMS offer brain
      imaging, growth hormone testing, and cardiac arrhythmia screening
    explanation: Linden 2009 recommends growth hormone testing as part of a broader UMS clinical workup.
- name: Cardiac Arrhythmia Screening (ECG and Echocardiography)
  description: >
    ECG and echocardiography to evaluate for ventricular septal defect,
    Wolff-Parkinson-White-pattern pre-excitation, and other conduction
    abnormalities, which may be under-ascertained in classical UMS
    descriptions.
  diagnosis_term:
    preferred_term: electrocardiography
    term:
      id: NCIT:C38053
      label: Electrocardiography
  evidence:
  - reference: PMID:30820409
    reference_title: "Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients with TBX3 mutations should be evaluated for conduction block and ventricular preexcitation"
    explanation: Direct clinical recommendation that TBX3 mutation carriers receive electrophysiological screening.
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we suggest that clinicians caring for individuals with UMS offer brain
      imaging, growth hormone testing, and cardiac arrhythmia screening
    explanation: Linden 2009 explicitly recommends cardiac arrhythmia screening in UMS patients.
treatments:
- name: Recombinant Human Growth Hormone
  description: >
    Recombinant human growth hormone (rhGH) replacement for growth hormone
    deficiency from anterior pituitary hypoplasia. Reported to improve
    height in UMS probands with confirmed GH deficiency.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: somatropin
      term:
        id: NCIT:C837
        label: Somatropin
  target_mechanisms:
  - target: Hypothalamic-Pituitary Axis Disruption
    evidence:
    - reference: PMID:36748390
      reference_title: "Ulnar-Mammary syndrome with TBX3 gene mutation in a Chinese family: A case report and literature review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The proband then was treated with recombinant human growth hormone (rhGH)
        and human chorionic gonadotropin (hCG). After a year and a half, his height
        and secondary sexual characteristics were significantly improved.
      explanation: Clinical response supports replacement downstream of the pituitary-axis defect without claiming correction of the developmental lesion.
  target_phenotypes:
  - preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  - preferred_term: Growth hormone deficiency
    term:
      id: HP:0008240
      label: Secondary growth hormone deficiency
  evidence:
  - reference: PMID:36748390
    reference_title: "Ulnar-Mammary syndrome with TBX3 gene mutation in a Chinese family: A case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "his height and secondary sexual characteristics were significantly"
    explanation: Treatment with rhGH and hCG significantly improved height and secondary sexual characteristics in a UMS proband.
- name: Testosterone and Gonadotropin Therapy for Pubertal Induction
  description: >
    Testosterone replacement or fertility-preserving FSH plus human
    chorionic gonadotropin (hCG) regimens can induce puberty in UMS males
    with persistent hypogonadotropic hypogonadism; hCG can also improve
    micropenis.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Hypothalamic-Pituitary Axis Disruption
    evidence:
    - reference: PMID:30550377
      reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Human chorionic gonadotrophin was given starting from a dose of 1000 up to
        2000 UI twice a week with increments of 500 UI every 6 months and
        up-titrating the dose according to TTe levels (4, 17, 18).
      explanation: The replacement regimen acts downstream of the pituitary lesion and therefore modulates its endocrine consequences rather than the structural defect.
  target_phenotypes:
  - preferred_term: Hypogonadotropic hypogonadism
    term:
      id: HP:0000044
      label: Hypogonadotropic hypogonadism
  - preferred_term: Delayed puberty
    term:
      id: HP:0000823
      label: Delayed puberty
  - preferred_term: Micropenis
    term:
      id: HP:0000054
      label: Micropenis
  evidence:
  - reference: PMID:40485890
    reference_title: "Clinical and genetic analysis of ulnar-mammary syndrome caused by a novel TBX3 mutation in a Chinese boy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "After \nhalf a year of treatment with human chorionic gonadotropin (HCG), the micropenis \nwas significantly improved"
    explanation: hCG therapy improved micropenis in a UMS proband with hypogonadotropic hypogonadism.
  - reference: PMID:30550377
    reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He received testosterone enanthate treatment for 9 months, but at 16 years
      and 11 months, the testis volume was −4.9 SDS (according to Joustra et al.
      (15)), and puberty was induced with FSH priming (75 IU for three times a
      week for 4 months) (16), followed by an induction scheme with FSH (150 IU
      for 3 times a week).
    explanation: Documents testosterone use followed by FSH-based pubertal induction in a molecularly confirmed UMS patient.
  - reference: PMID:30550377
    reference_title: "Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in Ulnar-Mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Human chorionic gonadotrophin was given starting from a dose of 1000 up to
      2000 UI twice a week with increments of 500 UI every 6 months and
      up-titrating the dose according to TTe levels (4, 17, 18).
    explanation: Provides the reported hCG component and biochemical titration strategy for the combined induction regimen.
- name: Cardiac Surveillance
  description: >
    Routine cardiac evaluation including echocardiogram and ECG to
    detect ventricular septal defects and conduction abnormalities
    (including Wolff-Parkinson-White-pattern pre-excitation), since
    these may be under-ascertained in classical clinical descriptions.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  - preferred_term: Wolff-Parkinson-White syndrome
    term:
      id: HP:0001716
      label: Wolff-Parkinson-White syndrome
  evidence:
  - reference: PMID:30820409
    reference_title: "Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients with TBX3 mutations should be evaluated for conduction block and ventricular preexcitation"
    explanation: Directly recommends screening TBX3 carriers for both major conduction-system manifestations.
  - reference: PMID:19938096
    reference_title: "Ulnar Mammary syndrome and TBX3: expanding the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we suggest that clinicians caring for individuals with UMS offer brain
      imaging, growth hormone testing, and cardiac arrhythmia screening
    explanation: Independent UMS case-series recommendation supports cardiac arrhythmia surveillance.
animal_models:
- species: Mus musculus
  genotype: Heterozygous Tbx3 loss-of-function and mammary-development alleles
  description: >-
    Mouse Tbx3 dosage models reproduce failure to maintain mammary placodes and
    reduced ductal branching, while developmental studies resolve the posterior
    limb-boundary mechanism. These models capture tissue-specific consequences
    of reduced Tbx3 dosage rather than the full variably expressed human syndrome.
  genes:
  - preferred_term: TBX3
    term:
      id: hgnc:11602
      label: TBX3
  modeled_mechanisms:
  - target: Posterior Limb Patterning Disruption
    description: Models TBX3-dependent positioning of the posterior boundary and SHH organizer territory.
    evidence:
    - reference: PMID:38828908
      reference_title: "TBX3 is essential for establishment of the posterior boundary of anterior genes and upregulation of posterior genes together with HAND2 during the onset of limb bud development."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "the \nposterior expression boundaries of anterior genes are positioned by \nTBX3-mediated repression, which excludes anterior genes such as Gli3, Alx4, \nHand1 and Irx3/5 from the posterior limb bud mesenchyme"
      explanation: Defines the posterior limb-boundary readout captured by the mouse model.
  - target: Apocrine Gland Development Failure
    description: Models the dosage-sensitive mammary placode and ductal branching defect.
    evidence:
    - reference: PMID:16222716
      reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "we show a haploinsufficiency effect of Tbx3 on maintenance of \nthe mammary placodes and on the extent of branching of the ductal tree in mice"
      explanation: Directly identifies the mammary developmental phenotype of reduced Tbx3 dosage.
  evidence:
  - reference: PMID:16222716
    reference_title: "Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we show a haploinsufficiency effect of Tbx3 on maintenance of \nthe mammary placodes and on the extent of branching of the ductal tree in mice"
    explanation: Establishes an in-vivo dosage model for a central UMS developmental mechanism.
- species: Drosophila melanogaster
  genotype: Humanized TBX3 model expressing p.P134S and comparison variants
  description: >-
    A humanized fly system compares developmental effects of TBX3 variants in
    different protein regions. It supports pathogenicity and domain-level
    functional stratification, but does not reproduce the human organ-system
    phenotype.
  genes:
  - preferred_term: TBX3
    term:
      id: hgnc:11602
      label: TBX3
  modeled_mechanisms:
  - target: TBX3 Haploinsufficiency
    description: Tests how disease-associated variants alter TBX3 activity and localization in a developmental context.
    evidence:
    - reference: PMID:39320041
      reference_title: "An inherited TBX3 alteration in a prenatal case of ulnar-mammary syndrome: Clinical assessment and functional characterization in Drosophila melanogaster."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Phenotypic analysis in flies, coupled with in silico modeling on the TBX3
        variants, suggested that the c.400 C > T is UMS-causing and impacts TBX3
        localization.
      explanation: States the functional and localization readouts of the humanized model.
  evidence:
  - reference: PMID:39320041
    reference_title: "An inherited TBX3 alteration in a prenatal case of ulnar-mammary syndrome: Clinical assessment and functional characterization in Drosophila melanogaster."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we generated a Drosophila humanized model for TBX3 to study the
      developmental consequences of the p.P134S as well as of other variants
      targeting different regions of the protein.
    explanation: Explicitly establishes the humanized fly model and its variant-comparison purpose.
differential_diagnoses:
- name: Holt-Oram Syndrome
  disease_term:
    preferred_term: Holt-Oram syndrome
    term:
      id: MONDO:0007732
      label: Holt-Oram syndrome
  description: >-
    TBX5-related Holt-Oram syndrome also combines upper-limb and cardiac
    findings, but classically affects anterior/radial limb structures rather
    than the posterior/ulnar structures of UMS; mammary, apocrine and genital
    findings favor TBX3-related disease.
  distinguishing_features:
  - Posterior ulnar-ray deficiency in UMS versus anterior radial-ray deficiency in Holt-Oram syndrome
  - Mammary and axillary apocrine hypoplasia favor UMS
  - Causative TBX3 variant in UMS versus TBX5 variant in Holt-Oram syndrome
  evidence:
  - reference: PMID:9207801
    reference_title: "Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Limb abnormalities of ulnar-mammary syndrome involve posterior elements.
      Mutations in TBX5, a related and linked gene, cause anterior limb
      abnormalities in Holt-Oram syndrome.
    explanation: Directly states the limb-pattern distinction between the two T-box disorders.
review_notes: >-
  The reviewed graph deliberately leaves Postaxial Hand Polydactyly, Absent
  Axillary Hair, Micropenis, Cryptorchidism, Ventricular Septal Defect,
  Hypodontia, Bifid Nasal Tip, Bifid Tongue, Imperforate Hymen, and Bladder
  Diverticulum without incoming causal edges. Their occurrence is supported,
  but the retained cache does not establish disorder-specific intermediate
  routes. Hypoplastic Nipples and Hypohidrosis remain connected because the
  mammary-placode model and human apocrine-gland series provide suitably scoped
  support. No population-based prevalence estimate, disease-modifying trial,
  or GeneReviews chapter was identified.

📚

References & Deep Research

Deep Research

1

Falcon ▸

Ulnar‑Mammary Syndrome (UMS) — Disease Characteristics Research Report

Edison Scientific Literature 25 citations 2026-04-26T20:16:30.324743

Ulnar‑Mammary Syndrome (UMS) — Disease Characteristics Research Report

Target disease

Disease name: Ulnar‑Mammary Syndrome (UMS)
Category: Mendelian developmental disorder
MONDO ID: Not available in retrieved evidence corpus (not present in accessed full text)

Executive overview

Ulnar‑mammary syndrome (UMS) is a rare, pleiotropic, typically autosomal dominant developmental disorder primarily affecting posterior (ulnar‑ray) limb development and mammary/apocrine gland development, with frequent genital/endocrine involvement and variable expressivity across and within families. UMS is caused by heterozygous deleterious variants in TBX3, a T‑box transcription factor critical for patterning and organogenesis, with haploinsufficiency widely supported as the predominant mechanism (galazzi2018hypogonadotropichypogonadismand pages 1-2, tung2022tbx3andefna4 pages 1-2, bottillo2024aninheritedtbx3 pages 1-2).

1. Disease information

1.1 Definition and current understanding

UMS is consistently described as a developmental malformation syndrome involving limb, mammary/apocrine, dentition, and genital development, with additional endocrine and occasional cardiac/other congenital anomalies reported (galazzi2018hypogonadotropichypogonadismand pages 1-2, tung2022tbx3andefna4 pages 1-2, bottillo2024aninheritedtbx3 pages 1-2).

1.2 Key identifiers

OMIM (disease): 181450 (UMS) (zhang2023literaturereviewreport pages 1-3, tung2022tbx3andefna4 pages 1-2)
OMIM (gene): TBX3 *601621 (tung2022tbx3andefna4 pages 1-2)
Orphanet: referenced as an authoritative rare disease resource and as the basis for the commonly cited count of published cases; disease page URL is cited directly in a 2022 peer‑reviewed report: https://www.orpha.net/consor/cgi-bin/Disease_Search.php?Ing=EN&data_id=2808&Disease_Search_diseaseGroup=Ulnar-mammary-syndrome&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group/group%20of%20diseases=Ulnar-mammary-syndrome&title=Ulnar-mammary%20syndrome&search=Disease_Search_Simple (accessed 31 Aug 2022 as reported) (tung2022tbx3andefna4 pages 1-2)
ICD‑10/ICD‑11, MeSH, MONDO: Not present in retrieved full‑text evidence; therefore not asserted here.

1.3 Synonyms / alternative names

Schinzel syndrome / Shinzel syndrome (noted as an alternative name in recent literature) (bottillo2024aninheritedtbx3 pages 1-2)

1.4 Evidence source type

The information summarized here is derived from aggregated disease‑level resources embedded in peer‑reviewed articles (e.g., Orphanet‑based counts) and individual patient/family reports and case series/reviews (e.g., Linden 2009; Galazzi 2018; Zhang 2023; Bottillo 2024; Tung 2022) (zhang2023literaturereviewreport pages 1-3, galazzi2018hypogonadotropichypogonadismand pages 1-2, linden2009ulnarmammarysyndrome pages 1-2, tung2022tbx3andefna4 pages 1-2, bottillo2024aninheritedtbx3 pages 1-2).

2. Etiology

2.1 Disease causal factors

Genetic: Heterozygous deleterious variants in TBX3 cause UMS (galazzi2018hypogonadotropichypogonadismand pages 1-2, tung2022tbx3andefna4 pages 1-2, bamshad1999thespectrumof pages 1-2).

Mechanistic framing (current): UMS is generally framed as a dosage‑sensitive developmental transcription‑factor disorder, with haploinsufficiency commonly invoked; however, experimental work in mice supports that not all TBX3 alterations behave as simple nulls (e.g., truncated/mislocalized proteins may contribute) (frank2013mousetbx3mutants pages 1-2, tung2022tbx3andefna4 pages 1-2).

2.2 Risk factors

For a Mendelian disorder, the main risk factor is inheritance of a pathogenic TBX3 variant. Familial transmission and intrafamilial variability are repeatedly documented (tung2022tbx3andefna4 pages 2-4, linden2009ulnarmammarysyndrome pages 1-2).

2.3 Protective factors

Not established in the retrieved evidence.

2.4 Gene–environment interactions

Not established in the retrieved evidence.

3. Phenotypes

3.1 Core phenotype domains (with suggested HPO mappings)

UMS exhibits substantial variable expressivity and sometimes subtle signs in carriers (linden2009ulnarmammarysyndrome pages 1-2, tung2022tbx3andefna4 pages 1-2).

A) Limb anomalies (posterior/ulnar ray)

Typical findings: posterior upper limb deficiencies ranging from mild fifth‑finger anomalies to severe forearm/hand reduction; may be asymmetric (galazzi2018hypogonadotropichypogonadismand pages 1-2, tung2022tbx3andefna4 pages 1-2).
Example patient detail (2023): absent left ulna and absent 4th/5th metacarpals/phalanges (zhang2023literaturereviewreport pages 1-3).
Suggested HPO terms:
Ulnar hypoplasia/aplasia (e.g., HP:0003048 ulnar hypoplasia; confirm exact HPO ID during curation)
Postaxial polydactyly (HP:0100259)
Fifth finger abnormalities (clinodactyly/camptodactyly; e.g., HP:0004209, HP:0001239)

B) Mammary/nipple and apocrine features

Findings: nipple hypoplasia/inversion/retraction; apocrine hypoplasia manifested as reduced sweating and absent/reduced axillary hair (galazzi2018hypogonadotropichypogonadismand pages 1-2, zhang2023literaturereviewreport pages 1-3).
Suggested HPO terms:
Inverted/retracted nipples (e.g., HP:0002562 inverted nipples)
Hypohidrosis (HP:0000966)
Sparse axillary hair (e.g., HP:0002230 sparse body hair)

C) Genital / reproductive anomalies (often male)

Findings: micropenis, cryptorchidism, delayed puberty; hypogonadotropic hypogonadism may be congenital and persistent (galazzi2018hypogonadotropichypogonadismand pages 1-2, zhang2023literaturereviewreport pages 1-3).
Suggested HPO terms:
Micropenis (HP:0000054)
Cryptorchidism (HP:0000028)
Delayed puberty (HP:0000823)
Hypogonadotropic hypogonadism (HP:0000044)

D) Endocrine / pituitary and growth

Pituitary hypoplasia and nIHH: documented as recurrent features in an endocrine‑focused study (galazzi2018hypogonadotropichypogonadismand pages 1-2, galazzi2018hypogonadotropichypogonadismand pages 5-6).
Short stature / growth hormone deficiency: reported in multiple cases, with pituitary structural abnormalities; one report explicitly proposes routine evaluation (linden2009ulnarmammarysyndrome pages 1-2, zhang2023literaturereviewreport pages 5-6).
Suggested HPO terms:
Short stature (HP:0004322)
Growth hormone deficiency (HP:0000824)
Pituitary hypoplasia (HP:0000873)

E) Dental anomalies / midline anomalies

Midline defects including “nose, teeth and tongue anomalies” are noted in endocrine‑focused familial cases (galazzi2018hypogonadotropichypogonadismand pages 1-2).
Suggested HPO terms:
Abnormal dentition (HP:0006482)
Midline defect (use specific terms depending on phenotype)

3.2 Phenotype frequencies/statistics (from recent analyses)

Published case count: approximately 128 cases reported worldwide (recently reiterated) (zhang2023literaturereviewreport pages 1-3, tung2022tbx3andefna4 pages 1-2).
Delayed puberty in males: 79% (combined analysis in an endocrine‑focused synthesis) (galazzi2018hypogonadotropichypogonadismand pages 1-2).
Other signs of hypogonadism in males: 37% (same combined analysis) (galazzi2018hypogonadotropichypogonadismand pages 1-2).
Short stature: reported in about ~16% of cases in a 2023 literature synthesis (zhang2023literaturereviewreport pages 5-6).

3.3 Quality of life impact

Direct quantitative QoL instruments were not reported in the retrieved evidence. However, real‑world impacts are implied by the need for orthopedic interventions for limb malformations, endocrine therapy for pubertal induction/fertility and growth, and cardiac surveillance/management when defects occur (linden2009ulnarmammarysyndrome pages 1-2, galazzi2018hypogonadotropichypogonadismand pages 5-6).

4. Genetic / molecular information

4.1 Causal gene

TBX3 encodes a T‑box transcription factor (DNA‑binding domain) important for embryonic development and organogenesis; heterozygous deleterious variants cause UMS (galazzi2018hypogonadotropichypogonadismand pages 1-2, bamshad1999thespectrumof pages 1-2).

4.2 Pathogenic variant classes and examples

UMS‑associated variants include truncating (frameshift/nonsense), splice‑site, and missense variants, including variants downstream of the T‑box domain; missense variants in the T‑box domain are highlighted as functionally impactful in a 2024 functional study (bottillo2024aninheritedtbx3 pages 1-2, bamshad1999thespectrumof pages 1-2).

Representative recent variants: - Frameshift (pathogenic): TBX3 c.1121_1124delAGAG (p.Glu374fs) (WES + Sanger; ACMG pathogenic) (zhang2023literaturereviewreport pages 1-3). - Missense (likely pathogenic, functional follow‑up): TBX3 c.400C>T (p.P134S), prenatally ascertained; functional characterization performed using a humanized Drosophila model (bottillo2024aninheritedtbx3 pages 1-2, bottillo2024aninheritedtbx3 pages 2-4). - Splice‑site (likely pathogenic): TBX3 c.804+1G>A, identified by NGS; marked intrafamilial variability reported (tung2022tbx3andefna4 pages 1-2, tung2022tbx3andefna4 pages 2-4).

Population frequency statements: - The p.P134S variant is reported as absent from gnomAD in the 2024 report (bottillo2024aninheritedtbx3 pages 2-4).

4.3 Functional consequences

Haploinsufficiency is widely discussed as the prevailing mechanism (galazzi2018hypogonadotropichypogonadismand pages 1-2, bottillo2024aninheritedtbx3 pages 1-2).
Experimental mouse genetics show that some engineered “null” alleles can generate truncated/mislocalized TBX3 proteins and yield phenotypes different from a true null allele, supporting that not all TBX3 variants are functionally equivalent (frank2013mousetbx3mutants pages 1-2).

4.4 Modifier genes / epigenetics / chromosomal abnormalities

Modifier genes: not established in the retrieved evidence; variable expressivity is emphasized (bottillo2024aninheritedtbx3 pages 1-2, tung2022tbx3andefna4 pages 1-2).
Epigenetic information: not directly described for UMS in retrieved evidence.
Chromosomal abnormalities: not systematically reviewed in the retrieved evidence corpus; however, TBX3 can be interrogated by methods beyond sequencing (e.g., genomic testing strategies discussed for broader diagnostic workups) (tung2022tbx3andefna4 pages 1-2).

5. Environmental information

UMS is not presented as environmentally caused. No consistent environmental contributors were identified in the retrieved evidence.

6. Mechanism / pathophysiology

UMS is best understood as a developmental gene regulatory network disorder due to reduced TBX3 function during embryogenesis, disrupting patterning and epithelial–mesenchymal interactions in multiple organ systems.

6.1 Limb patterning (2024 mechanistic advance)

A 2024 mouse developmental genomics study places TBX3 directly in early limb‑bud anteroposterior patterning: - TBX3 is required to establish the posterior boundary of anterior genes by repression that excludes factors such as Gli3, Alx4, Hand1 and Irx3/5 from posterior limb‑bud mesenchyme, thereby delineating a posterior territory competent to establish the SHH organizer (soussi2024tbx3isessential pages 1-2). - HAND2 cooperates with TBX3 to upregulate posterior identity targets and is required for SHH activation (soussi2024tbx3isessential pages 1-2).

Suggested GO biological process terms (examples): limb development; anterior/posterior pattern specification; regulation of transcription by RNA polymerase II. Suggested cell types (CL): limb bud mesenchymal cell (map to appropriate CL term during curation).

6.2 Retinoic acid signaling as an upstream regulator of TBX3 in limb development

A mechanistic cell/developmental biology study demonstrates that Tbx3 is a direct target of retinoic acid signaling: - “retinoic acid (RA) activates endogenous TBX3 expression… mediated by an RA–receptor complex directly binding and activating the TBX3 promoter” with evidence for relevance in mouse embryonic limb development (ballim2012theulnarmammarysyndrome pages 1-2).

Pathway suggestions: retinoic acid signaling; transcriptional regulation.

6.3 Mammary/apocrine development and dosage sensitivity

Mouse developmental work indicates TBX3 dosage sensitivity in mammary development: - Tbx3 is “essential for induction of the mammary placodes” and shows a haploinsufficiency effect on maintenance of mammary placodes and ductal branching; genetic interaction with Tbx2 is described, with effects not clearly mediated by p19Arf/p53 in that context (jerome‐majewska2005tbx3theulnar‐mammary pages 1-2).

6.4 Endocrine/pituitary mechanism (clinical inference)

Endocrine case series data show that congenital normosmic hypogonadotropic hypogonadism (nIHH) can be associated with pituitary hypoplasia in UMS and can persist into adulthood, supporting TBX3 involvement in hypothalamic–pituitary development/function (galazzi2018hypogonadotropichypogonadismand pages 1-2).

7. Anatomical structures affected

7.1 Organ and system level

Musculoskeletal/limb: posterior upper limb/ulnar ray; digits; forearm bones (zhang2023literaturereviewreport pages 1-3, galazzi2018hypogonadotropichypogonadismand pages 1-2).
Integumentary/apocrine: axillary hair and sweat glands (apocrine involvement inferred clinically by reduced perspiration) (galazzi2018hypogonadotropichypogonadismand pages 1-2).
Breast/nipple: nipple/breast development and potentially lactation (galazzi2018hypogonadotropichypogonadismand pages 1-2).
Reproductive system: external male genitalia and testes; pubertal development (galazzi2018hypogonadotropichypogonadismand pages 1-2).
Endocrine (pituitary): pituitary size/structure and hypothalamic–pituitary axis function (galazzi2018hypogonadotropichypogonadismand pages 1-2, linden2009ulnarmammarysyndrome pages 1-2).
Cardiac (subset): congenital heart defect and conduction abnormalities are reported; a clinical report recommends screening (linden2009ulnarmammarysyndrome pages 1-2).

7.2 Suggested UBERON mappings (examples)

Upper limb (UBERON:0002101)
Mammary gland (UBERON:0001911)
Pituitary gland (UBERON:0000007)
Testis (UBERON:0000473)

8. Temporal development

Onset: congenital (limb, nipple/apocrine anomalies present from birth), with endocrine manifestations often recognized in childhood/adolescence via growth failure or delayed puberty (zhang2023literaturereviewreport pages 1-3, galazzi2018hypogonadotropichypogonadismand pages 1-2).
Course: structural anomalies are lifelong; endocrine deficiencies may require long‑term management and can persist into adulthood (nIHH persistence reported) (galazzi2018hypogonadotropichypogonadismand pages 1-2).

9. Inheritance and population

9.1 Inheritance

Autosomal dominant inheritance is consistently stated (zhang2023literaturereviewreport pages 1-3, tung2022tbx3andefna4 pages 1-2).
Variable expressivity is emphasized (linden2009ulnarmammarysyndrome pages 1-2, tung2022tbx3andefna4 pages 1-2).
Incomplete penetrance is stated in a 2023 report (zhang2023literaturereviewreport pages 3-4).

9.2 Epidemiology

UMS is extremely rare; a commonly repeated literature‑based estimate is ~128 published cases worldwide (zhang2023literaturereviewreport pages 1-3, tung2022tbx3andefna4 pages 1-2). Prevalence/incidence rates were not provided in retrieved full text.

10. Diagnostics

10.1 Clinical suspicion

Clues supporting diagnosis include posterior limb defects (ulnar ray), nipple/apocrine anomalies (inverted nipples, reduced sweating, absent axillary hair), and genital/endocrine findings (micropenis, cryptorchidism, delayed puberty), with high phenotypic variability (galazzi2018hypogonadotropichypogonadismand pages 1-2, zhang2023literaturereviewreport pages 1-3).

10.2 Genetic testing (real‑world implementations)

Documented approaches include: - Whole‑exome sequencing (WES) with Sanger confirmation and ACMG classification (example: pathogenic frameshift) (zhang2023literaturereviewreport pages 1-3). - Targeted NGS panels (example: CLIA panel used in a UMS/craniosynostosis context; also endocrine gene panels including TBX3) (tung2022tbx3andefna4 pages 2-4, galazzi2018hypogonadotropichypogonadismand pages 1-2). - Whole‑genome sequencing (WGS) as a follow‑up in complex/overlapping phenotypes (tung2022tbx3andefna4 pages 2-4).

10.3 Endocrine and imaging workup

The endocrine‑focused paper emphasizes that UMS should be suspected in patients with delayed puberty and midline defects including pituitary hypoplasia, even without obvious limb malformations, and that TBX3 should be included in candidate gene lists for congenital nIHH (galazzi2018hypogonadotropichypogonadismand pages 1-2).
A clinical report suggests offering brain imaging, growth hormone testing, and cardiac arrhythmia screening because these findings may be under‑ascertained (linden2009ulnarmammarysyndrome pages 1-2).

10.4 Differential diagnosis

Not systematically enumerated in the retrieved evidence; however, overlap with other “heart–hand” and limb malformation syndromes is implied by the need for careful genetic workup and variable presentations (tung2022tbx3andefna4 pages 1-2).

11. Outcome / prognosis

UMS outcomes are driven by the severity of congenital malformations and endocrine/cardiac complications. No disease‑specific survival statistics were identified in retrieved evidence. Severe cardiac conduction disease can be clinically significant when present, supporting surveillance (linden2009ulnarmammarysyndrome pages 1-2).

12. Treatment

No disease‑modifying molecular therapy is described in retrieved evidence; management is supportive and complication‑directed.

12.1 Endocrine management (documented real‑world practice)

Growth hormone replacement was instituted for growth hormone deficiency with pituitary abnormalities (clinical report) (linden2009ulnarmammarysyndrome pages 1-2).
Management regimens for hypogonadotropic hypogonadism/delayed puberty include testosterone for pubertal induction and gonadotropin‑based regimens (FSH priming and hCG) described as applied in UMS patients with nIHH (galazzi2018hypogonadotropichypogonadismand pages 2-3, galazzi2018hypogonadotropichypogonadismand pages 5-6).

12.2 Surgical/interventional

Cryptorchidism may be treated with orchidopexy (clinical report) (linden2009ulnarmammarysyndrome pages 1-2).
Orthopedic/rehabilitative care is implied for limb malformations; specific protocols are not detailed in retrieved evidence.

12.3 MAXO suggestions (examples)

Growth hormone therapy (MAXO term to be assigned during ontology curation)
Testosterone replacement / pubertal induction
Orchidopexy
Genetic counseling

13. Prevention

Primary prevention is not applicable for an inherited dominant developmental disorder, but reproductive and familial risk reduction approaches apply: - Genetic counseling is indicated given autosomal dominant inheritance and intrafamilial variability (tung2022tbx3andefna4 pages 1-2, linden2009ulnarmammarysyndrome pages 1-2). - Prenatal diagnosis can occur when a familial variant is known; a 2024 report describes prenatal ascertainment and subsequent family re‑evaluation (bottillo2024aninheritedtbx3 pages 1-2).

14. Other species / natural disease

No naturally occurring veterinary syndrome directly analogous to human UMS was identified in the retrieved evidence. However, TBX3 has conserved roles across species.

15. Model organisms

15.1 Drosophila (2024)

A 2024 study developed a humanized Drosophila model expressing TBX3 variants (including p.P134S) to assess developmental consequences and variant functional impact; the work argues this model can dissect TBX3‑dependent developmental pathways relevant to UMS (bottillo2024aninheritedtbx3 pages 1-2, bottillo2024aninheritedtbx3 pages 2-4).

15.2 Mouse developmental models

Mechanistic and phenotypic mouse evidence underpins UMS understanding: - RA regulation of Tbx3 in limb development (ballim2012theulnarmammarysyndrome pages 1-2). - Early limb‑bud patterning role of Tbx3 (2024 ChIP‑seq and expression studies) (soussi2024tbx3isessential pages 1-2). - Mammary placode induction/maintenance and branching morphogenesis dosage sensitivity (jerome‐majewska2005tbx3theulnar‐mammary pages 1-2).

Recent developments (emphasis 2023–2024)

2023 clinical genetics expansion: a novel pathogenic TBX3 frameshift (c.1121_1124delAGAG; p.Glu374fs) was reported, with detailed endocrine and pituitary imaging phenotyping and reiteration of rarity (~128 cases) (zhang2023literaturereviewreport pages 1-3).
2024 functional variant interpretation: prenatal case with a novel TBX3 missense (p.P134S) and functional characterization using a humanized Drosophila model, alongside an updated constitutional variant spectrum emphasizing the importance of the T‑box domain for missense pathogenicity (bottillo2024aninheritedtbx3 pages 1-2, bottillo2024aninheritedtbx3 pages 2-4).
2024 mechanistic limb‑bud genomics: TBX3 positioned as a key repressor establishing anterior gene boundaries in posterior mesenchyme and cooperating with HAND2 to promote posterior identity and SHH organizer formation (soussi2024tbx3isessential pages 1-2).

Direct quotes (for evidence traceability)

Galazzi et al. 2018 (abstract): “The combined analysis of these findings and of the previous UMS reports showed delayed puberty and other signs of hypogonadism in 79 and 37% of UMS males, respectively.” (galazzi2018hypogonadotropichypogonadismand pages 1-2)
Zhang et al. 2023 (background): “To date, approximately 128 cases have been reported worldwide, and only 2 cases have been reported in China (including this case).” (zhang2023literaturereviewreport pages 1-3)
Ballim et al. 2012 (abstract): “retinoic acid (RA) activates endogenous TBX3 expression, which is mediated by an RA–receptor complex directly binding and activating the TBX3 promoter…” (ballim2012theulnarmammarysyndrome pages 1-2)

Summary artifact

Key identifiers, variant examples, and phenotype statistics are summarized here:

Item type	Detail	Source (first author year)	URL/DOI
Identifier / nomenclature	Ulnar-mammary syndrome (UMS); OMIM #181450; described as a rare autosomal dominant disorder with marked clinical heterogeneity (zhang2023literaturereviewreport pages 1-3, tung2022tbx3andefna4 pages 1-2)	Zhang 2023	https://doi.org/10.3389/fped.2023.1052931
Identifier / nomenclature	Alternative eponym: Schinzel syndrome; UMS also referenced in Orphanet disease listings and case summaries (bottillo2024aninheritedtbx3 pages 1-2, tung2022tbx3andefna4 pages 1-2)	Bottillo 2024	https://doi.org/10.1002/jcp.31440
Causal gene / mechanism	TBX3 (OMIM 601621) is the causal gene; UMS results from heterozygous TBX3 variants, usually via haploinsufficiency* (galazzi2018hypogonadotropichypogonadismand pages 1-2, bottillo2024aninheritedtbx3 pages 1-2)	Galazzi 2018	https://doi.org/10.1530/EC-18-0486
Causal gene / mechanism	TBX3 is a developmental T-box transcription factor required for limb, mammary/apocrine, genital and pituitary-related development; 2024 mechanistic data show TBX3 helps establish posterior limb-bud identity and cooperates with HAND2 in early limb patterning (soussi2024tbx3isessential pages 1-2, ballim2012theulnarmammarysyndrome pages 1-2)	Soussi 2024	https://doi.org/10.1242/dev.202722
Variant (representative)	c.804+1G>A (TBX3 intron 3 canonical splice-site); novel likely pathogenic splice variant in a family with UMS and marked intrafamilial variability (tung2022tbx3andefna4 pages 2-4, tung2022tbx3andefna4 pages 1-2)	Tung 2022	https://doi.org/10.3390/genes13091649
Variant (representative)	c.1121_1124delAGAG (p.Glu374fs); pathogenic frameshift identified by exome sequencing/Sanger confirmation in a Chinese boy with short stature, ulnar hypoplasia, hypohidrosis, retracted nipples, micropenis, and cryptorchidism (zhang2023literaturereviewreport pages 1-3)	Zhang 2023	https://doi.org/10.3389/fped.2023.1052931
Variant (representative)	c.400C>T (p.P134S); novel likely pathogenic missense variant in the T-box domain, absent from gnomAD in the report, functionally assessed in a Drosophila humanized model (bottillo2024aninheritedtbx3 pages 2-4, bottillo2024aninheritedtbx3 pages 1-2)	Bottillo 2024	https://doi.org/10.1002/jcp.31440
Variant spectrum	Constitutional TBX3 variant spectrum includes truncating, splice-site, missense, insertion/deletion, and downstream-of-T-box variants; pathogenic missense variants are enriched in the T-box domain (bottillo2024aninheritedtbx3 pages 2-4, bamshad1999thespectrumof pages 1-2)	Bottillo 2024	https://doi.org/10.1002/jcp.31440
Phenotype statistic	Approximately 128 cases of UMS had been published/reported worldwide in recent reviews/case summaries (zhang2023literaturereviewreport pages 1-3, tung2022tbx3andefna4 pages 1-2)	Zhang 2023	https://doi.org/10.3389/fped.2023.1052931
Phenotype statistic	In combined analysis of prior reports, delayed puberty occurred in 79% of UMS males (galazzi2018hypogonadotropichypogonadismand pages 1-2)	Galazzi 2018	https://doi.org/10.1530/EC-18-0486
Phenotype statistic	In combined analysis of prior reports, other signs of hypogonadism occurred in 37% of UMS males (galazzi2018hypogonadotropichypogonadismand pages 1-2)	Galazzi 2018	https://doi.org/10.1530/EC-18-0486
Phenotype statistic	Short stature has been reported in about 16% of cases in literature summarized by recent review (zhang2023literaturereviewreport pages 5-6)	Zhang 2023	https://doi.org/10.3389/fped.2023.1052931
Phenotype statistic	Core prepubertal recognition features emphasized in 2024 review/function study: ulnar/ulnar-ray defects, hypoplastic nipples/areolae, and less often male genital anomalies (bottillo2024aninheritedtbx3 pages 1-2)	Bottillo 2024	https://doi.org/10.1002/jcp.31440

Table: This table compacts the key disease identifiers, causal gene/mechanism, representative recent TBX3 variants, and the main phenotype statistics reported for ulnar-mammary syndrome. It is useful as a quick reference for knowledge-base curation and report drafting.

Key limitations of this report

PMIDs were not available in the retrieved full‑text snippets; therefore this report cites DOIs/URLs and publication dates from the accessed articles.
MONDO/MeSH/ICD codes, prevalence/incidence estimates, and population allele frequency tables were not present in the retrieved corpus; these should be supplemented by direct queries to MONDO, MeSH, ICD, ClinVar, and gnomAD in a future update.

References

(galazzi2018hypogonadotropichypogonadismand pages 1-2): Elena Galazzi, Paolo Duminuco, Mirella Moro, Fabiana Guizzardi, Nicoletta Marazzi, Alessandro Sartorio, Sabrina Avignone, Marco Bonomi, Luca Persani, and Maria Teresa Bonati. Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in ulnar-mammary syndrome. Endocrine Connections, 7:1432-1441, Dec 2018. URL: https://doi.org/10.1530/ec-18-0486, doi:10.1530/ec-18-0486. This article has 15 citations and is from a peer-reviewed journal.
(tung2022tbx3andefna4 pages 1-2): Moon Ley Tung, Bharatendu Chandra, Jaclyn Kotlarek, Marcelo Melo, Elizabeth Phillippi, Cristina M. Justice, Anthony Musolf, Simeon A. Boyadijev, Paul A. Romitti, Benjamin Darbro, and Hatem El-Shanti. Tbx3 and efna4 variant in a family with ulnar-mammary syndrome and sagittal craniosynostosis. Genes, 13:1649, Sep 2022. URL: https://doi.org/10.3390/genes13091649, doi:10.3390/genes13091649. This article has 5 citations.
(bottillo2024aninheritedtbx3 pages 1-2): Irene Bottillo, Andrea D'Alessandro, Maria Pia Ciccone, Gianluca Cestra, Gianluca Di Giacomo, Evelina Silvestri, Marco Castori, Francesco Brancati, Andrea Lenzi, Alessandro Paiardini, Silvia Majore, Giovanni Cenci, and Paola Grammatico. An inherited tbx3 alteration in a prenatal case of ulnar‐mammary syndrome: clinical assessment and functional characterization in drosophila melanogaster. Journal of Cellular Physiology, Sep 2024. URL: https://doi.org/10.1002/jcp.31440, doi:10.1002/jcp.31440. This article has 3 citations and is from a peer-reviewed journal.
(zhang2023literaturereviewreport pages 1-3): Xiwen Zhang, Lifen Chen, Lin Li, Jingjing An, Qinyu He, Xuelei Zhang, Wenli Lu, Yuan Xiao, and Zhiya Dong. Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome. Frontiers in Pediatrics, Mar 2023. URL: https://doi.org/10.3389/fped.2023.1052931, doi:10.3389/fped.2023.1052931. This article has 6 citations.
(linden2009ulnarmammarysyndrome pages 1-2): Helen Linden, Rosy Williams, Janet King, Edward Blair, and Usha Kini. Ulnar mammary syndrome and tbx3: expanding the phenotype. American Journal of Medical Genetics Part A, 149A:2809-2812, Dec 2009. URL: https://doi.org/10.1002/ajmg.a.33096, doi:10.1002/ajmg.a.33096. This article has 87 citations.
(bamshad1999thespectrumof pages 1-2): M. Bamshad, M. Bamshad, Trung Le, W. Watkins, Missy Dixon, Bridget E. Kramer, Amy D. Roeder, John C. Carey, S. Root, A. Schinzel, L. V. Maldergem, R. Gardner, R. Lin, Christine E. Seidman, J. G. Seidman, R. Wallerstein, Ellen Moran, R. Sutphen, Christine E. Campbell, and L. Jorde. The spectrum of mutations in tbx3: genotype/phenotype relationship in ulnar-mammary syndrome. American journal of human genetics, 64 6:1550-62, Jun 1999. URL: https://doi.org/10.1086/302417, doi:10.1086/302417. This article has 234 citations and is from a highest quality peer-reviewed journal.
(frank2013mousetbx3mutants pages 1-2): Deborah U. Frank, Uchenna Emechebe, Kirk R. Thomas, and Anne M. Moon. Mouse tbx3 mutants suggest novel molecular mechanisms for ulnar-mammary syndrome. PLoS ONE, 8:e67841, Jul 2013. URL: https://doi.org/10.1371/journal.pone.0067841, doi:10.1371/journal.pone.0067841. This article has 56 citations and is from a peer-reviewed journal.
(tung2022tbx3andefna4 pages 2-4): Moon Ley Tung, Bharatendu Chandra, Jaclyn Kotlarek, Marcelo Melo, Elizabeth Phillippi, Cristina M. Justice, Anthony Musolf, Simeon A. Boyadijev, Paul A. Romitti, Benjamin Darbro, and Hatem El-Shanti. Tbx3 and efna4 variant in a family with ulnar-mammary syndrome and sagittal craniosynostosis. Genes, 13:1649, Sep 2022. URL: https://doi.org/10.3390/genes13091649, doi:10.3390/genes13091649. This article has 5 citations.
(galazzi2018hypogonadotropichypogonadismand pages 5-6): Elena Galazzi, Paolo Duminuco, Mirella Moro, Fabiana Guizzardi, Nicoletta Marazzi, Alessandro Sartorio, Sabrina Avignone, Marco Bonomi, Luca Persani, and Maria Teresa Bonati. Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in ulnar-mammary syndrome. Endocrine Connections, 7:1432-1441, Dec 2018. URL: https://doi.org/10.1530/ec-18-0486, doi:10.1530/ec-18-0486. This article has 15 citations and is from a peer-reviewed journal.
(zhang2023literaturereviewreport pages 5-6): Xiwen Zhang, Lifen Chen, Lin Li, Jingjing An, Qinyu He, Xuelei Zhang, Wenli Lu, Yuan Xiao, and Zhiya Dong. Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome. Frontiers in Pediatrics, Mar 2023. URL: https://doi.org/10.3389/fped.2023.1052931, doi:10.3389/fped.2023.1052931. This article has 6 citations.
(bottillo2024aninheritedtbx3 pages 2-4): Irene Bottillo, Andrea D'Alessandro, Maria Pia Ciccone, Gianluca Cestra, Gianluca Di Giacomo, Evelina Silvestri, Marco Castori, Francesco Brancati, Andrea Lenzi, Alessandro Paiardini, Silvia Majore, Giovanni Cenci, and Paola Grammatico. An inherited tbx3 alteration in a prenatal case of ulnar‐mammary syndrome: clinical assessment and functional characterization in drosophila melanogaster. Journal of Cellular Physiology, Sep 2024. URL: https://doi.org/10.1002/jcp.31440, doi:10.1002/jcp.31440. This article has 3 citations and is from a peer-reviewed journal.
(soussi2024tbx3isessential pages 1-2): Geoffrey Soussi, Ausra Girdziusaite, Shalu Jhanwar, Victorio Palacio, Marco Notaro, Rushikesh Sheth, Rolf Zeller, and Aimée Zuniga. Tbx3 is essential for establishment of the posterior boundary of anterior genes and upregulation of posterior genes together with hand2 during the onset of limb bud development. Development, Jun 2024. URL: https://doi.org/10.1242/dev.202722, doi:10.1242/dev.202722. This article has 7 citations and is from a domain leading peer-reviewed journal.
(ballim2012theulnarmammarysyndrome pages 1-2): Reyna Deeya Ballim, Cathy Mendelsohn, Virginia E. Papaioannou, and Sharon Prince. The ulnar-mammary syndrome gene, tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development. Molecular Biology of the Cell, 23:2362-2372, Jun 2012. URL: https://doi.org/10.1091/mbc.e11-09-0790, doi:10.1091/mbc.e11-09-0790. This article has 29 citations and is from a domain leading peer-reviewed journal.
(jerome‐majewska2005tbx3theulnar‐mammary pages 1-2): Loydie A. Jerome‐Majewska, Gerard P. Jenkins, Elana Ernstoff, Frederique Zindy, Charles J. Sherr, and Virginia E. Papaioannou. Tbx3, the ulnar‐mammary syndrome gene, and tbx2 interact in mammary gland development through a p19arf/p53‐independent pathway. Developmental Dynamics, 234:922-933, Dec 2005. URL: https://doi.org/10.1002/dvdy.20575, doi:10.1002/dvdy.20575. This article has 117 citations and is from a peer-reviewed journal.
(zhang2023literaturereviewreport pages 3-4): Xiwen Zhang, Lifen Chen, Lin Li, Jingjing An, Qinyu He, Xuelei Zhang, Wenli Lu, Yuan Xiao, and Zhiya Dong. Literature review, report, and analysis of genotype and clinical phenotype of a rare case of ulnar-mammary syndrome. Frontiers in Pediatrics, Mar 2023. URL: https://doi.org/10.3389/fped.2023.1052931, doi:10.3389/fped.2023.1052931. This article has 6 citations.
(galazzi2018hypogonadotropichypogonadismand pages 2-3): Elena Galazzi, Paolo Duminuco, Mirella Moro, Fabiana Guizzardi, Nicoletta Marazzi, Alessandro Sartorio, Sabrina Avignone, Marco Bonomi, Luca Persani, and Maria Teresa Bonati. Hypogonadotropic hypogonadism and pituitary hypoplasia as recurrent features in ulnar-mammary syndrome. Endocrine Connections, 7:1432-1441, Dec 2018. URL: https://doi.org/10.1530/ec-18-0486, doi:10.1530/ec-18-0486. This article has 15 citations and is from a peer-reviewed journal.

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Prevalence

Differential Diagnoses

Animal Models

Source YAML

References & Deep Research

Deep Research

Ulnar‑Mammary Syndrome (UMS) — Disease Characteristics Research Report

Target disease

Executive overview

1. Disease information

1.1 Definition and current understanding

1.2 Key identifiers

1.3 Synonyms / alternative names

1.4 Evidence source type

2. Etiology

2.1 Disease causal factors

2.2 Risk factors

2.3 Protective factors

2.4 Gene–environment interactions

3. Phenotypes

3.1 Core phenotype domains (with suggested HPO mappings)

A) Limb anomalies (posterior/ulnar ray)

B) Mammary/nipple and apocrine features

C) Genital / reproductive anomalies (often male)

D) Endocrine / pituitary and growth

E) Dental anomalies / midline anomalies

3.2 Phenotype frequencies/statistics (from recent analyses)

3.3 Quality of life impact

4. Genetic / molecular information

4.1 Causal gene

4.2 Pathogenic variant classes and examples

4.3 Functional consequences

4.4 Modifier genes / epigenetics / chromosomal abnormalities

5. Environmental information

6. Mechanism / pathophysiology

6.1 Limb patterning (2024 mechanistic advance)

6.2 Retinoic acid signaling as an upstream regulator of TBX3 in limb development

6.3 Mammary/apocrine development and dosage sensitivity

6.4 Endocrine/pituitary mechanism (clinical inference)

7. Anatomical structures affected

7.1 Organ and system level

7.2 Suggested UBERON mappings (examples)

8. Temporal development

9. Inheritance and population

9.1 Inheritance

9.2 Epidemiology

10. Diagnostics

10.1 Clinical suspicion

10.2 Genetic testing (real‑world implementations)

10.3 Endocrine and imaging workup

10.4 Differential diagnosis

11. Outcome / prognosis

12. Treatment

12.1 Endocrine management (documented real‑world practice)

12.2 Surgical/interventional

12.3 MAXO suggestions (examples)

13. Prevention

14. Other species / natural disease

15. Model organisms

15.1 Drosophila (2024)

15.2 Mouse developmental models

Recent developments (emphasis 2023–2024)

Direct quotes (for evidence traceability)

Summary artifact

Key limitations of this report